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Rotavirus A (RVA), belongs to genus Rotavirus, family Reoviridae, is a major cause 
of acute diarrhoea in infants and young children worldwide. Its genome comprises 11 
segments of double-stranded RNA that encode 6 structural viral proteins (VPs) and 6 
nonstructural proteins (NSPs).  
The development of nucleotide sequencing technology over the last few decades made 
it increasingly feasible to characterise rotavirus strains at the level of nucleotide sequence, 
advancing the molecular epidemiology of RVA. When it comes to the targets of molecular 
epidemiological studies, two kinds of strains are two be distinguished; predominant strains 
and uncommon ones. The former are the strains that predominate and their information is 
crucial to develop preventive strategies such as vaccines. The latter are uncommon or novel 
strains and the characterisation of such exceptional strains often provide clues to understand 
how RVA evolves in nature.  
Over the course of my PhD studies I have addressed the guestions concerning the 
molecular epidemiology of RVA strains oby characterising two actual examples of the two 
kinds of strains archived in the Department of Hygiene and Molecular Epidemiology, 
Graduate School of Biomedical Sciences, Nagasaki University to understand the evolutionary 
mechanisms of RVA. The first study was concerned with the molecular characterisation of the 
predominant strains: G2 strains detected in Japan during 31 years before the introduction of 
rotavirus vaccines. The second study was concerned with the molecular characterisation of an 
uncommon strain: a rare super-short strain named AU19 possessing genotype G1P[6] detected 
in 1997 in Japan. AU19 was the first and the only strain (until very recently) in terms of either 




The aims of the study 
The objective of the first study was to examine how the VP7 genes of G2 strains 
evolved over a 31 year period before the introduction of rotavirus vaccines in Japan. The 
objective of the second study was to determine the full-genome sequence of the AU19 strain 
to understand how such a rare P[6] rotavirus strain with a super-short RNA pattern emerged in 
nature.  Through these two sets of specific studies, I aimed to gain a better understanding of 
how RVA strains evolved under unvaccinated conditions. 
Materials and Methods 
From archival rotavirus-positive stool specimens collected from Japanese children 
with diarrhoea between 1980 and 2011, 35 G2 strains were chosen, and their VP7 genes were 
sequenced. I also sequenced 10 genome segments of the AU19 strain (as the VP7 gene was 
already sequenced and published previously). Phylogenetic analysis was conducted using the 
MEGA 5 software package. Amino acid substitutions were analysed at positions 87, 96, 213, 
and 242 in the G2 VP7 genes which were previously identified to carry evolutionary 
importance. 
Results 
All Japanese G2 strains evolved along the stepwise changes from lineage III, lineage I, 
group IV except IVa and sub-lineage IVa (lineage II was absent in Japan). As a potential next 
step of the evolutionary change, I observed the emergence of what I named “a nascent lineage” 
outside of the currently and globally predominant lineage (i.e., sub-lineage IVa). This nascent 
lineage contained a D96N substitution, which is the hallmark of modern G2 lineage (i.e., sub-
lineage IVa) and was previously shown to get involved in the change in neutralisation 
specificity of G2 strains. 
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Full-genome sequence analysis revealed that all genome segments of AU19 were more 
closely related to those of porcine RVA strains than those of human RVA strains except the 
NSP5 gene. The NSP5 genome segment contained a rare rearranged NSP5 sequence that was 
typed as H2 (by the online typing tool of RotaC). It belonged to H2b sub-genotype but 
distantly related to the H2b sequences previously identified in human RVA strains. These 
observations indicated that AU19 emerged as a consequence of complex evolutionary events: 
interspecies transmission of a porcine rotavirus to a child coupled with acquisition of a rare 
rearranged NSP5 gene (H2b genotype) by genetic reassortment probably from a co-circulating 
human RVA strain (because the H2b genotype was known to occur only in human RVA). The 
finding of a rare H2b NSP5 gene of AU19 which was originated from human rotavirus made 
the genetic diversity of H2b genotype as diverse as that of the H2a genotype, leading to the 
hypothesis that super-short strains carrying H2b genotype have long been circulating 
unnoticed in the human population.   
Conclusions 
Molecular characterisation of Japanese RVA strains analysed in this thesis revealed: 
(1) the genes of RVA strains are likely to evolve in nature through the accumulation of point 
mutations resulting in the emergence of a new lineage in a stepwise fashion (a lineage 
followed by another) as exemplified by the nascent lineage in the G2 VP7 gene; (2) 
interspecies transmission of animal RVA strains to humans (and subsequent genetic 
reassortment) is likely to have played an important evolutionary role, when succeeded in 
establishing a human-to-human transmission chain, as exemplified by a rare porcine-like 
human RVA strain AU19 (although AU19 appears to have ended in dead-end infection). 
However, it remains to be seen whether the accumulation of point mutations will be 
accelerated and interspecies reassortant strains will have a survival advantage over co-
circulating human RVA strains under selective pressures imposed by wide-spread use of 
vaccines. Further studies are, therefore, warranted to monitor at the full-genome level if such 
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emerging strains will spread globally. Such studies should help to ensure the successful use of 




CHAPTER 1. INTRODUCTION 
 
Rotavirus A, a member of the genus Rotavirus, family Reoviridae, is a major cause of 
acute diarrhoea in infants and young children where rotavirus vaccines are not introduced into 
the national immunisation programmes (Tate et al., 2012). Molecular epidemiology of RVA is 
concerned with the understanding of the distribution of wild-type strains in the temporal, 
geographical and population’s perspectives as well as with the evolution of RVA. The targets 
of molecular epidemiological studies are roughly divided into strains that constitute the 
majority (predominant strains) and uncommon strains; the former provides the basis on which 
preventive strategies are built and the latter provides clues to understand the evolution of 
RVA in nature. Two outer capsid proteins, VP7 and VP4, are independently involved in virus 
neutralisation and define the G type and P type, respectively, have been paid much attention 
because of its importance in protective immunity. Although there are 27 G types and 37 P 
types described in the literature , the vast majority of human RVA strains have one of the 6 
major G and P type combinations; G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8] 
(Banyai et al., 2012, Doro et al., 2014, Gentsch et al., 2005, Matthijnssens et al., 2011, Santos 
and Hoshino, 2005, Trojnar et al., 2013).  
Since 2009 when two globally licensed vaccines were recommended to be included in 
national immunisation programmes by the World Health Organisation (WHO) (WHO, 2009), 
the concern was raised about the effectiveness of these vaccines to the G2 strains which were 
partly or fully heterotypic to the vaccine strains. A series of studies showed natural fluctuation 
of the relative frequency of circulating G2 strains and the relationship of amino acid 
substitutions occurring in the VP7 gene with the re-emergence or an increase in frequency of 
G2 strains (Antunes et al., 2009, Esteban et al., 2010, Iturriza-Gomara et al., 2009, Kirkwood 
et al., 2011, Luchs et al., 2011, Martinez et al., 2010, Santos and Hoshino, 2005, Snelling et 
al., 2011, Vieira et al., 2011). In addition, the D96N substitution in the VP7 gene was the 
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salient feature of G2 strains circulating in the world for the last decade, even when and where 
the rotavirus vaccines were introduced (Doan et al., 2011).  
Studies based on G and P genotypes alone may miss differences in the genotype 
constellation that only occur in the internal capsid and non-structural protein genes where 
human rotavirus-specific genotypes are replaced with unusual or animal rotavirus-specific 
genotypes. The whole genome sequences studies include the remaining capsid and non-
structural protein genes enabling us to study rotaviruses as a whole rather than just the outer 
layer of the virion (Matthijnssens et al., 2008a, Matthijnssens et al., 2011). The two prototype 
strains, Wa and DS-1, which represent two distinct RNA migration patterns: long and short 
electropherotypes, are described as G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 and G2-P[4]-I2-
R2-C2-M2-A2-N2-T2-E2-H2, respectively (Matthijnssens et al., 2008a). Super-short 
electropherotypes may infrequently appear with the rearranged 11th genome segment making 
it become longer than that of short electropherotype strains (Dyall-Smith and Holmes, 1981, 
Kutsuzawa et al., 1982). A rare super-short human RVA strain, named AU19, was shown to 
carry a unique P[6] VP4 gene and it was later suspected to be originated from porcine 
rotavirus when some Japanese porcine RVA strains were investigated for their VP4 genes 
(Ahmed et al., 2007, Nakagomi et al., 1999, Teodoroff et al., 2005). Although 
rare/usual/minority strains may not immediately affect the public health of people as, by 
definition they are very few in numbers, they are likely to give us a clue to understand the 
evolutionary mechanisms of RVA strains under natural conditions. 
Over the course of my PhD studies I have addressed the issues concerning the 
evolutionary mechanisms of RVA strains through molecular characterisation of two actual 
examples archived in the Department of Hygiene and Molecular Epidemiology. The first 
study was concerned with the molecular characterisation of the predominant strains: G2 
strains detected in Japan during 31 years before the introduction of rotavirus vaccines. The 
second study was concerned with the molecular characterisation of an uncommon strain: a 
rare super-short strain named AU19 possessing genotype G1P[6] detected in 1997 in Japan. 
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AU19 was the first and only strain (until very recently) in terms of either “super-short” 
genome pattern or P[6] genotype.  
The objective of the first study was to examine how the G2 VP7 gene possessed by 
RVA strains evolved over a 31 year period before the introduction of rotavirus vaccines in 
Japan. The objective of the second study was to determine the full-genome sequence of the 
AU19 strain to understand how such a rare P[6] rotavirus strain with a super-short RNA 
pattern emerged in nature. Through these two sets of specific studies, I aimed to have a better 




CHAPTER 2. RESULTS 
 
In this thesis, I analysed the nucleotide sequences of the VP7 genes of the 35 G2P[4] 
rotavirus strains collected between 1983 and 2014 and the nearly full genome sequence of a 
rare G1P[6] AU19 strain detected in 1997 in Japan.  
 2.1. Molecular evolution of the VP7 gene of Japanese G2 rotaviruses before vaccine 
introduction 
The sequences of 35 G2 rotavirus strains determined in this study were compiled with 
20 Japanese G2 VP7 sequences available in the GenBank database to analyse the dataset that 
contained a total of 55 G2 VP7 sequences from Japanese strains detected over the period of 
31 years (1980-2011). There was, however, a 7-year period (1993-2000) in which no VP7 
sequence was available for G2 strains in the literature. 
The phylogenetic tree was constructed using the 55 Japanese G2 VP7 nucleotide 
sequences along with 488 G2 sequences that were obtained from the DNA databases (Fig.2.1). 
Four lineages and four sub-lineages were identified in the phylogenetic tree as defined by 
Doan et al. (2011) as shown in Fig.2.1 where lineages and sub-lineages were collapsed to 





Fig.2.1. A phylogenetic tree based on the global G2 VP7 nucleotide sequences. The tree was 
constructed using the neighbor-joining method with bootstrap probabilities after 1,000 
replicate trials. The lineages and sub-lineages are collapsed to make the topological 
relationship clearer. At the right-hand side of the figure are the lineages and sub-lineages 
defined by Doan et al (2011). The genetic distance is indicated at the bottom. Percent 
bootstrap support is indicated by the value at each node when the value was 70% or larger. 
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Fig.2.2 is a phylogenetic tree contained all 35 Japanese G2 VP7 sequences determined 
in this study (with dot) along with some G2 sequences representative of the lineages and sub-
lineages defined previously (Doan et al., 2011). The Japanese G2 VP7 sequences clustered 
into three lineages: lineage I, III and IV. Lineage I, which the VP7 sequence of DS-1, the 
prototype G2 strain, belonged to, contained only one Japanese G2 strain isolated in 1983 
(83A001). The nucleotide sequence identities between 83A001 and other G2 VP7 sequences 
in this lineage including those from Taiwanese, South African and Australian strains were 
>97.9%. Lineage III contained only two Japanese strains which were detected in a single year 
of 1980, and they were 99.9% identical in the nucleotide sequence. The vast majority of 
Japanese G2 strains (50/54) belonged to lineage IV, which further divided into three 
independent groups. Two thirds (33) of strains belonged to one group whose bootstrap value 
was only 62%; hence incapable of being named as sub-lineage. One third (18) of the 
remaining strains clustered into sub-lineage IVa-1 with a bootstrap value of 94% and the 
mean p-distance within this group was 0.008. Only one strain, B100056, detected in 2011 


























































































































































Fig.2.2. A phylogenetic 
tree  based on 35 Japanese 
G2 VP7 nucleotide 
sequences determined in 
this study (indicated in 
boldface with dots) 
together with 20 Japanese 
G2 VP7 nucleotide (in 
boldface) and 
representative sequences 
obtained from the 
GenBank database. A 
nascent lineage is 
highlighted in grey 
shadow. The tree was 
constructed using the 
neighbor-joining method 
with bootstrap 
probabilities after 1,000 
replicate trials. The 
genetic distance is 
indicated at the bottom. 
Percent bootstrap support 
is indicated by the value 
at each node when the 
value was 70% or larger. 
Five porcine G2 strains 
were used as the outgroup 
strains, which are not 
shown in the tree. Only 
the node where the root is 




When the lineage distribution of Japanese G2VP7 sequences was examined along the 
timeline from 1980 to 2011, a few observations were made. There was the co-circulation of 
Japanese G2 strains that belonged to three lineages: lineage I, lineage III and group IV except 
IVa in the early 1980s (Fig.2.3). Japanese G2 strains in lineages I and III never appeared 
again since the early 1980s. In contrast, G2 strains belonging to group IV except IVa 
continued to circulate much longer until 1993 and with an interruption of 18 years, two 
Japanese G2 strains (B100005, B100119) belonging to this group re-emerged in 2011 
(Fig.2.3). These two Japanese strains formed a nascent lineage supported by a high bootstrap 
probabilities of 99% with other three G2 strains detected in Germany in 2008 (GER177-08), 
detected in Belgium in 2009 (BE1248) and detected in Australia in 2011 (CK20047) (Fig.2.2). 
Other than these two strains, after 2000, most of the rotavirus G2 strains in Japan belonged to 
sub-lineage IVa-1. In 2011, we noticed one strain (B100056) belonging to sub-lineage IVa-3 














Fig.2.3. The distribution of G2 strains in Japan by the year of detection and the lineages to 



























With respect to the four amino acid positions 87, 96, 213 and 242 in the VP7 antigenic 
regions previously described as potential epitopes for G2 strains by Doan et al. (Doan et al., 
2011), the 83A001 strain, the only Japanese G2 strain belonging to lineage I, had the same 
amino acid pattern with the DS-1 strain, the reference strain of lineage I: A-D-N-N at 
positions 87, 96, 213 and 242, respectively (Fig.2.4). Two Japanese G2 strains detected in 
1980 belonging to lineage III that had two amino acid substitutions A87T and N242S; hence, 
these sequences had an amino acid constellation T-D-N-S (Fig.2.4). All Japanese G2 
sequences belonging to group IV except IVa had the same substitution N213D and N242S 
from the amino acid constellation of the lineage I strains (Fig.2.4). A further amino acid 
substitution D96N was noted in five G2 strains in this group that were detected after 2007 and 
they belonged to the nascent lineage; hence two different amino acid constellations, A-D-D-S 
and A-N-D-S, in the group IV except IVa (Fig.2.4). The amino acid constellation of sub-
lineage IVa-1 was T-N-D-S which was completely different from that of DS-1 (Fig.2.4). One 
peculiar exception to the rule for sub-lineage IVa-1 was a strain detected in Nara Prefecture in 
2009, 90096, which contained glycine at residue 96, a very unusual amino acid at this position 
(Fig.2.4). Finally, in 2011, a strain belonging sub-lineage IVa-3 with the amino acid 




Fig.2.4. The amino acid constellation at residues 87, 96, 213 and 242 in the VP7 antigenic 
regions of various G2 strains shown in Fig.2.2 including those detected in Japan between 
1980 and 2011.  
  
A A C F A A C F A A C F
(87) (96) (213) (242) (87) (96) (213) (242) (87) (96) (213) (242)
DS-1 USA 1976 A D N N DS-1 USA 1976 A D N N DS-1 USA 1976 A D N N
DS-1 USA 1976 A D N N S2 Japan 1981 A D D S
Hu5 Australia 1977 A D N N TA81 Taiwan 1981 T D D S TD64 Taiwan 1992 T N D S
TA3 Taiwan 1981 A D N N Japan022 Japan 1983 A D D S Bangla84 Bangladesh 1994 T N D S
83A001 Japan 1983 A D N N Japan038 Japan 1983 A D D S 356PT South Africa 1996 T N D S
GR410 South Africa 1985 A D N N 85A21410 Japan 1985 A D D S Mvd9707 Uruguay 1997 T N N S
86A005 Japan 1986 A D D S KY3103 Kenya 1999 T N D S
86Y187 Japan 1986 A D D S Py40699 Paraquay 1999 T N D S
92A Australia 1992 A D S S 86Y1329 Japan 1986 A D D S CIT-220RV Ireland 2000 T N N S
1831GR South Africa 1993 A D S S 87Y003 Japan 1987 A D D S KO2 Japan 2001 T N D S
H105-Palermo Italy 1996 T D S S 87H038 Japan 1987 A D D S 01P007 Japan 2001 T N D S
Rj5619 Brazil 2002 T D N S 87Y1438 Japan 1987 A D D S 01P008 Japan 2001 T N D S
Nov04-H383 Russia 2004 T D S S 88F007 Japan 1988 A D D S 01P012 Japan 2001 T N D S
88Y259 Japan 1988 A D D S 01P014 Japan 2001 T N D S
88H449 Japan 1988 A D D S 01P017 Japan 2001 T N D S
KUN Japan 1980 T D N S 88Y1112 Japan 1988 A D D S 01P129 Japan 2001 T N D S
TMCII Japan 1980 T D N S 89A049 Japan 1989 A D D S 01R137 Japan 2001 T N D S
89H279 Japan 1989 A D D S CMH277 Thailand 2001 T N D S
89H354 Japan 1989 A D D S J-4708 Japan 2001-2003 T N D S
89Y1520 Japan 1989 A D D S J-4709 Japan 2001-2003 T N D S
90Y289 Japan 1990 A D D S J-4765 Japan 2001-2003 T N D S
90H377 Japan 1990 A D D S J-4777 Japan 2001-2003 T N D S
90H415 Japan 1990 A D D S J-4787 Japan 2001-2003 T N D S
CHIN8 China 1990 A D D S VN-11 Vietnam 2002 T N D S
90H094 Japan 1990 A D D S CH-130 China 2003 T N D S
90H115 Japan 1990 A D D S 26-Palermo Italy 2003 T N D S
90Y593 Japan 1990 A D D S SL244 Sierra Leone 2005 T N D S
92H006 Japan 1992 A D D S LB2772 USA 2005-2006 T N D S
92H085 Japan 1992 A D D S Arg2395 Argentina 2007 T N D S
92H102 Japan 1992 A D D S 14322/07MG Brazil 2007 T N D S
JAPAN58 Japan 1992 A D D S 07Y003 Japan 2007 T N D S
JAPAN076 Japan 1993 A D D S 80004 Japan 2008 T N D S
JAPAN085 Japan 1993 A D D S 80120 Japan 2008 T N D S
JAPAN137 Japan 1992 A D D S 80123 Japan 2008 T N D S
PAK426 Pakistan 1993 A D D S GER84 Germany 2008 T N D S
TE29 Taiwan 1993 A D D S Seoul-556 South Korea 2009 T N D S
TWCH105 Thailand 1994 A D D S 90096 Japan 2009 T G D S
TB-Chen China 1996 A D D S
KY3303 Kenya 1999 A D D S
GH1803 Ghana 1999 T N D S
4476PT South Africa 1997 T N D S
GER177 Germany 2008 A N D S
BE1248 Belgium 2009 A N D S
CK20047 Australia 2011 A N D S Bangla66 Bangladesh 1993 T N D N
B100005 Japan 2011 A N D S NG5113 Negeria 1999 T N D N
B100119 Japan 2011 A N D S MR 4717 Mauritius 2000 T N D N
XJ00-486 China 2000 T N D N
DC2020 Madagascar 2004 T N D N
Matlab6 Bangladesh 2004 T N D N
05N011 Nepal 2005 T N D N
LB2764 USA 2005-2006 T N D N
mani-268 India 2007 T N D N
GER31 Germany 2008 T N D N
MMA08-4 Myanmar 2008 T N D N
CU110-BK Thailand 2008 T N D N
Seoul-397 South Korea 2009 T N D N
16054 09MA Brazil 2009 T N D N















Group IV except IVa
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 2.2. A rare G1P[6] super-short human rotavirus strain carrying an H2 genotype on the 
genetic background of a porcine rotavirus 
 In this study, we determined nearly-full nucleotide sequences of the genome segments 
coding for VP4, VP6, VP1-VP3, and NSP1- NSP5 genes of AU19 (Table 2.1).  
Table 2.1. The position and length of the sequence determined for each the 10 genome 
segments of AU19 
Segment Positions and length of sequence Accession number Reference 
VP4 23-2312 (2289) AB770153 This study 
VP6 151-1307 (1156) AB770154 This study 
VP1 28-3245 (3217) AB770155 This study 
VP2 65-2657 (2592) AB770156 This study 
VP3 87-2541 (2454) AB770157 This study 
NSP1 198 - 1363 (1166) AB770158 This study 
NSP2 48 - 1008 (961) AB770159 This study 
NSP3 58 -948 (891) AB770160 This study 
NSP4 51 - 738 (688) AB770161 This study 





 In consistent with its super-short electropherotype, the entire length of NSP5 gene of 
AU19 was 949 nucleotides, 128 and 329 nucleotides longer than DS-1 (a short 
electropherotype) and Wa (a long electropherotype), respectively, although the last 24 and 20 
nucleotides of 5’ and 3’ ends, respectively, were those of PCR primers. According to the 
whole genome-based genotyping system proposed by the Rotavirus Classification Working 
Group (RCWG) (Maes et al., 2009, Matthijnssens et al., 2008b)  the genotype of the VP7-
VP4-VP6-VP1-VP2-VP3-NSP1-NSP2-NSP3-NSP4-NSP5 genes of AU19 was assigned to 
G1-P[6]- I5-R1-C1-M1-A8-N1-T1-E1- H2. Since I5 and A8 genotypes are exclusively carried 
by porcine and porcine-like human rotaviruses (Matthijnssens et al., 2008a) the genotype 
constellation of AU19 was compared with that of selected human and porcine rotavirus strains 
as well as super-short human strains (Table 2.2).  
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Table 2.2. Comparison the genotype constellation of AU19 with other human and porcine rotavirus strains including reference strains, 
Wa and DS-1. Strain AU19 is in bold. The genome segments that have a genotype identical to that of AU19 are highlighted in gray. The 
gene segment whose sequence is the closest to that of AU19 is in bold and italicized. “-” indicates that no sequence data was available in 
the GenBank database. 
Strain VP7 VP4 VP6 VP1 VP2 VP3 NSP1 NSP2 NSP3 NSP4 NSP5 Reference 
RVA/Human-tc/JPN/AU19/1997/G1P[6] G1 P[6] I5 R1 C1 M1 A8 N1 T1 E1 H2 This study 
RVA/Human-tc/USA/Wa/1974/G1P[8] G1 P[8] I1 R1 C1 M1 A1 N1 T1 E1 H1 Matthijnssens et 
al., 2008a 
RVA/Pig-tc/GBR/SW20/21/1976/G1P[7] G1 P[7] - - - - - - - - - El-Attar et al., 
2001 
RVA/Human-tc/USA/DS-1/1974/G2P[4] G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2 Matthijnssens et 
al., 2008a 
RVA/Human-tc/JPN/AU-1/1982/G3P[9] G3 P[9] I3 R3 C3 M3 A3 N3 T3 E3 H3 Isegawa et al., 
1992, Nakagomi 
and Kaga, 1995, 
Rahman et al., 
2007 
RVA/Pig-tc/USA/Gottfried/1975/G4P[6] G4 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 Matthijnssens et 
al., 2010b 
RVA/Human-tc/IDN/57M/1980/G4P[10] G4 P10] I1 R1 C1 M1 A1 N1 T2 E1 H2 Ghosh et al., 
2013 








RVA/Horse-tc/GBR/H-1/1975/G5P[6] G5 P[7] I5 R1 C1 M1 A8 N1 T1 E1 H1 Ghosh et al., 
2012a 
RVA/Human-tc/IND/69M/1980/G8P[10] G8 P10] I2 R2 C2 M2 A2 N2 T2 E2 H2 Matthijnssens et 
al., 2008a 
RVA/Human-tc/IDN/B37/197x/G8P[10] G8 P[10] - - - - - - - - H2 Hum et al., 1989 
RVA/Pig-wt/JPN/JP3-6/2002/G9P[6] G9 P[6] - - - - - - - - - Teodoroff et al., 
2005 
RVA/Human-wt/BEL/BE2001/2009/G9P[6] G9 P[6] I5 R1 C1 M1 A8 N1 T7 E1 H1 Zeller et al., 
2012 
RVA/Human-tc/THA/Mc323/1989/G9P[19] G9 P[19] I5 R1 C1 M1 A8 N1 T1 E1 H1 Ghosh et al., 
2012b 
RVA/Human-tc/THA/Mc345/1989/G9P[19] G9 P[19] I5 R1 C1 M1 A8 N1 T1 E1 H1 Ghosh et al., 
2012b 
RVA/Human-wt/BEL/B4106/2000/G3P14] G3 P[14] I2 R2 C2 M3 A9 N2 T6 E5 H3 Matthijnssens et 
al., 2006 












G9 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 Mukherjee et al., 
2010 




 Phylogenetic trees were constructed for the genes encoding the structural and non-
structural proteins of AU19 (indicated with a black dot and in bold) with other human and 
animal (mainly porcine) rotavirus strains as references for the host species of origin. The 
trees were constructed using the neighbour-joining method included in the MEGA 5 
software package. The trees were statistically supported by bootstrapping with 1000 
replicates, and rooted with sequences of different genotypes. The actual lengths used for 
phylogenetic tree construction for the VP7, VP4, VP6, VP1, VP2, VP3, NSP1, NSP2, 
NSP3, NSP4, and NSP5 genes were 981, 501, 1157, 3218, 2593, 2455, 1166, 961, 891, 688, 
and 904 nucleotides, respectively.   
 In the phylogenetic analysis, the major observations for each gene were as follows. 
The VP7 phylogenetic tree shown in Fig.2.5 was drawn by including the first 100 
sequences that were hit when the AU19 VP7 sequence was blasted against the GenBank 
database. The AU19 sequence clustered together with the VP7 sequence of a G1 porcine 
strain SW20/21 isolated in UK in 1976 with a bootstrap probability of 97% (El-Attar et al., 
2001). The sequence identity between AU19 and SW20/21 was 90.6% at the nucleotide 
sequence level and 95% at the amino acid sequence level. On the other hand, the lineage 
that contained AU19 and SW20/21 was distinct from the lineage that all other human 
rotavirus strains clustered into (shown as a triangle for condensation in Fig.2.5). The 
average sequence identity between AU19 and human rotaviruses in the aggregated lineage 
was 87.5% (87.2% - 88.6%) at the nucleotide level and 92.2% (91.6% - 93.1%) at the 




Fig.2.5. Phylogenetic trees for the VP7 gene of AU19 (indicated with a black dot and in 
bold) with other human, porcine and bovine rotavirus strains as references for the host 
species of origin. The trees were statistically supported by bootstrapping with 1000 
replicates, used the neighbor-joining method included in the MEGA 5 software package, 
and rooted with DS-1 sequences as outgroup. The genetic distance is indicated at the 
bottom. Percent bootstrap support is indicated by the value at each node when the value 
was 70% or larger. An abbreviated term of HRVs is used to denote human rotaviruses. 
  
 In the VP4 phylogenetic tree which the VP8 regions of the first 100 sequences that 
were hit when the AU19 VP4 sequence was blasted against the GenBank database, the 
AU19 clustered into a lineage with a 99% bootstrap probability that contained four porcine 
rotaviruses detected in Japan (Fig.2.6). The average sequence identity between AU19 and 
the four Japanese porcine rotavirus strains was 90.9% (90.8% - 91.1%) at the nucleotide 
level and 83.2% (82.4% - 84.3%) at the amino acid level. This lineage was distinct from the 
lineage that the vast majority of human P[6] strains were clustered into (shown as a triangle 














Ryukyu-1120 (Komoto et al., 2013) or BE2001 (Zeller et al., 2012), two human rotavirus 
































































Fig.2.6. Phylogenetic tree of 
the partial VP8 portion of the 
VP4 gene of AU19 
(indicated with a black dot 
and in bold) with other 
human and porcine rotavirus 
strains. The trees were 
constructed by using the 
neighbor-joining method 
included in the MEGA 5 
software package, rooted 
with Wa sequences as 
outgroup and statistically 
supported by bootstrapping 
with 1000 replicates. The 
genetic distance is indicated 
at the bottom. Percent 
bootstrap support is indicated 
by the value at each node 




 In the VP6 phylogenetic tree which all I5 sequences were included, the vast 
majority were porcine rotaviruses as is known that I5 genotype is specific to porcine 
rotaviruses (Matthijnssens et al., 2008b). AU19 clustered together with porcine-like human 
rotavirus strains Ryukyu-1120 (Komoto et al., 2013), BE2001 (Zeller et al., 2012) and 
other porcine rotaviruses in the lineage which was only marginally supported statistically 

























































































Fig.2.7. Phylogenetic tree of the 
VP6 gene of AU19 (indicated with 
a black dot and in bold) with other 
human and porcine RVA strains. 
The trees were constructed using 
the neighbor-joining method 
included in the MEGA 5 software 
package and statistically supported 
by bootstrapping with 1000 
replicates. DS-1 was chosen as the 
outgroup. The genetic distance is 
indicated at the bottom. Percent 
bootstrap support is indicated by 
the value at each node when the 
value was 70% or larger. 
Abbreviated term of PRVs is used 




 In the VP1 phylogenetic tree that contained 491 R1 sequences available in the 
GenBank database, the vast majority of human rotavirus clustered into one large aggregated 
lineage with a bootstrap probability of 99% (Fig.2.8). By contrast, while the number of 
PRV sequences available was much smaller, PRVs segregated into several lineages each 
with a significantly high bootstrap value, sometimes together with unusual porcine-like 
human rotavirus strains such as Ryukyu-1120 and BE2001 (Komoto et al., 2013, Zeller et 
al., 2012) (Fig.2.8). AU19 clustered together only with an equine rotavirus strain H-1 
which was previously shown to be of porcine rotavirus origin (Ghosh et al., 2012a), 
although the origin of the H-1 VP1 gene was not unambiguously determined. The identity 
between AU19 and H-1 was calculated as 90.1% at the nucleotide sequence level and that 




























































Fig.2.8. Phylogenetic tree of the 
VP1 gene of AU19 (indicated 
with a black dot and in bold) 
with other human and animal 
(mainly porcine) rotavirus 
strains. The trees were 
constructed using the neighbor-
joining method included in the 
MEGA 5 software package and 
statistically supported by 
bootstrapping with 1000 
replicates. Pigeon rotavirus strain 
PO-13 was chosen as the 
outgroup. The genetic distance is 
indicated at the bottom. Percent 
bootstrap support is indicated by 
the value at each node when the 




 In the VP2 phylogenetic tree that contained 352 C1 VP2 sequences available in the 
GenBank database, only one lineage contained porcine rotaviruses including the prototype 
strain OSU (Fig.2.9). To this lineage belonged AU19 together with five human rotaviruses 
of probable porcine origin: Ryukyu-1120, BE2001, Mc323, Mc345, and mani-362/07 
(Zeller et al., 2012). In this lineage there were also 16 human rotavirus strains detected in 
Bethesda, USA, in 1991 (shown as a small triangle for condensation in Fig.2.9); however, it 
was reported that they were reassortants with rotaviruses of yet unidentified host species 
origin (McDonald et al., 2009). AU19 had 92.8% nucleotide identity to the rotavirus strains 
carrying the VP2 gene of unidentified origin, 95.6% to the porcine rotavirus OSU and 













































Fig.2.9. Phylogenetic tree of 
the VP2 gene of AU19 
(indicated with a black dot and 
in bold) with other human and 
animal (mainly porcine) 
rotavirus strains as references 
for the host species of origin. 
The trees were constructed 
using the neighbor-joining 
method included in the MEGA 
5 software package and 
statistically supported by 
bootstrapping with 1000 
replicates. Pigeon rotavirus 
strain PO-13 was chosen as the 
outgroup. The genetic distance 
is indicated at the bottom. 
Percent bootstrap support is 
indicated by the value at each 
node when the value was 70% 




 In the VP3 phylogenetic tree that contained 269 M1 sequences available in the 
GenBank database, AU19 clustered with porcine-like human strain Ryukyu-1120 (Komoto 
et al., 2013) with 99% of bootstrap probability and the nucleotide identity was 92% at the 
nucleotide sequence level (Fig.2.10). This lineage however clustered into a larger lineage 
with a bootstrap probability of 97% that contained porcine rotaviruses such as OSU and 
porcine-like equine rotavirus H-1 (Ghosh et al., 2012a). In addition, this lineage contained 




























Fig.2.10. Phylogenetic tree of the VP3 
gene of AU19 (indicated with a black dot 
and in bold) with other human strain, one 
horse strain and PRV strains. The trees 
were constructed using the neighbor-
joining method included in the MEGA 5 
software package and statistically 
supported by bootstrapping with 1000 
replicates. DS-1 strain was chosen as the 
outgroup. The genetic distance is 
indicated at the bottom. Percent 
bootstrap support is indicated by the 
value at each node when the value was 




 The NSP1 genotype carried by AU19 was A8, and this genotype was previously 
depicted as indicative of porcine rotavirus origin (Matthijnssens et al., 2008a). The AU19 
NSP1 sequence was located within a single large lineage that contained porcine rotaviruses 
and a few human rotaviruses of probable porcine rotavirus origin such as BE2001, Mc323, 
Mc345, and mani-362/07 (Ghosh et al., 2012a, Mukherjee et al., 2011, Zeller et al., 2012) 
(Fig.2.11).  
 
Fig.2.11. Phylogenetic tree of the NSP1 gene of AU19 (indicated with a black dot and in 
bold) with other human and porcine rotavirus strains. The trees were constructed using the 
neighbor-joining method included in the MEGA 5 software package and statistically 
supported by bootstrapping with 1000 replicates. PO-13 was chosen as the outgroup. The 
genetic distance is indicated at the bottom. Percent bootstrap support is indicated by the 








































 In the NSP2 phylogenetic tree that contained 684 N1 NSP2 sequences available in 
the GenBank database, the AU19 did not cluster with any rotaviruses of either human or 
bovine rotavirus origin with a statistically significant bootstrap value (Fig.2.12). However, 
the strain that had the highest nucleotide identity (94.6%) to AU19 was super-short human 











































































tree of the NSP2 gene of 
AU19 (indicated in bold) 
and other human and 
animal (mainly porcine) 
rotavirus strains as 
references for the host 
species of origin. The 
trees were constructed 
using the neighbor-
joining method included 
in the MEGA 5 software 
package and statistically 
supported by 
bootstrapping with 1000 
replicates. PO-13 was 
chosen as the outgroup. 
The genetic distance is 
indicated at the bottom. 
Percent bootstrap support 
is indicated by the value 
at each node when the 
value was 70% or larger.  
Abbreviated term of 





 In the NSP3 phylogenetic tree which the first 100 sequences that were hit when the 
AU19 VP7 sequence was blasted against the GenBank database were included, the AU19 was 
clustered into a lineage with a 90% bootstrap probability that contained all porcine rotaviruses 
except Ryukyu-1120 (Fig.2.13). This lineage was distinct from the lineage that the vast 
majority of human T1 strains clustered into (shown as an aggregated triangle in Fig.2.13). The 
strains that had the highest nucleotide identity (95.4%) to AU19 were Ryukyu-1120 and three 
porcine strains PRG942, PRG921, PRG9235 detected in Korea.  
 
Fig.2.13. Phylogenetic tree of the NSP3 gene of AU19 (indicated with a black dot and in 
bold) with other human and porcine rotavirus strains as references for the host species of 
origin. The trees were constructed using the neighbor-joining method included in the MEGA 
5 software package and statistically supported by bootstrapping with 1000 replicates. PO-13 
was chosen as the outgroup. The genetic distance is indicated at the bottom. Percent bootstrap 

































 In the NSP4 phylogenetic tree which the first 100 sequences that were hit when the 
AU19 VP7 sequence was blasted against the GenBank database were included, the AU19 did 
not cluster with any rotaviruses of either human or bovine rotavirus origin with statistically 
significant bootstrap supports (Fig.2.14). The strains that had the highest nucleotide identity 
(96%) to AU19 were four porcine rotavirus strains PRG942, PRG921, PRG9235, and 




 The phylogenetic tree shown in Fig.2.15 was drawn for the NSP5 sequences that 
belonged to H1, H2 and H3 genotypes. AU19 clustered into the sub-lineage that contained 
three super-short strains, 57M, B37, and 69M, with a bootstrap value of 94%. The sub-lineage 









































































Fig.2.14. Phylogenetic tree of the 
NSP4 gene of AU19 (indicated 
with a black dot and in bold) with 
other human and animal (mainly 
porcine) rotavirus strains as 
references for the host species of 
origin. The trees were constructed 
using the neighbor-joining 
method included in the MEGA 5 
software package and statistically 
supported by bootstrapping with 
1000 replicates. DS-1 was chosen 
as the outgroup. The genetic 
distance is indicated at the 
bottom. Percent bootstrap support 
is indicated by the value at each 




short strains with a bootstrap value of 69%, which increased to 87% when the nearly-full 3’ 
and 5’ non-coding sequences were taken into calculation (Fig.2.16).Within the NSP5 genes 
carried by the four super-short strains, the mean pair-wise distance was 2.3% with a range 
from 0 to 4.6%. Similarly, within the NSP5 genes carried by short strains, the mean pair-wise 
distance was 1.8% with a range from 0 to 4.2%. The pair-wise distance between sequences 
belonging to these two lineages (between H2a and H2b) ranged from 8.3 to 10.6% with a 
mean of 9.2%. On the other hand, the pair-wise distance within the H1 lineage ranged from 0 
to 6.9% with a mean of 2.2%, and had a bootstrap value of 99% at the branching point 
(Fig.2.15). Similarly, the pair-wise distance within the H3 lineage ranged from 0 to 8.5% with 
a mean of 4.9%, and had a bootstrap value of 94% at the branching point (Fig.2.15). The pair-




Fig.2.15. Phylogenetic tree of the ORF of the NSP5 gene of AU19 (indicated with a black dot 
and in bold) with other human and porcine rotavirus strains. The trees were constructed using 
the neighbour-joining method included in the MEGA 5 software package with bootstrap 
probabilities after 1,000 replicate trials, and rooted with sequences of different genotypes. The 
genetic distance is indicated at the bottom. Percent bootstrap support is indicated by the value 






























































Fig.2.16. Phylogenetic tree of the entire length of the NSP5 gene of AU19 (indicated with a 
black dot and in bold) with other human and porcine rotavirus strains. The trees were 
constructed using the neighbor-joining method included in the MEGA 5 software package 
with bootstrap probabilities after 1,000 replicate trials, and rooted with sequences of different 
genotypes. The genetic distance is indicated at the bottom. Percent bootstrap support is 





























































CHAPTER 3. DISCUSSION 
3.1. Molecular evolution of the VP7 gene of Japanese G2 rotaviruses before vaccine 
introduction: 
Molecular evolutionary analysis of the VP7 genes of Japanese G2 strains detected 
during the 31 year period (1980-2011) showed that the evolutionary process of the G2 VP7 
genes of Japanese G2 strains occurred in parallel with that of the global G2 strains as 
described by Doan et al. (Doan et al., 2011). The two oldest strains detected in 1980 belonged 
to the lineage III, one strain detected in 1983 belonged to the linage I to which prototype 
strain DS-1 belonged, the 33 strains detected between 1981 and 2011 belonged to the group 
IV except IVa, 18 strains detected between 2001 and 2009 belonged to the sub-linage IVa-1, 
and one strain detected in 2011 belonged to the sub-linage IVa-3. There was no Japanese G2 
strain belonging to lineage II. This observation was consistent with the previous study 
describing that no strain in lineage II was detected in Asia except one strain reported from the 
Asian part of Russia (Doan et al., 2011). 
The most interesting observation in this study that was different from what Doan et al. 
(Doan et al., 2011) concluded from their observations was the emergence of a nascent lineage 
outside of sub-lineage IVa and within group IV except IVa that was accompanied by the 
D96N substitution in the VP7 gene. Doan et al. (Doan et al., 2011) mentioned that the G2 
strains in group IV except IVa was not regarded as forming a lineage due to a low bootstrap 
probability and that the vast majority of these strains had the A-D-D-S amino acid 
constellation at position 87-96-213-242, respectively. However, in 2011, two Japanese G2 
strains belonging to group IV except IVa re-emerged after an 18-year interval. This 
emergence revealed the persistence of strains that belonged to group IV except IVa, which 
may be related to its genetic diversity as mentioned by Doan et al. (Doan et al., 2011). These 
two Japanese strains (B100005, B100119) formed a nascent lineage which was supported by a 
high bootstrap probability of 99% with other three G2 strains detected in Germany in 2008 
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(GER177-08), detected in Belgium in 2009 (BE1248) and detected in Australia in 2011 
(CK20047). More importantly, this nascent lineage had the D96N substitution that was shown 
to be the cardinal feature of strains that belong to lineage IVa. The amino acid at position 96 
was previously described as an epitope recognized by a G2-specific neutralizing monoclonal 
antibody (RV5:3) (Lazdins et al., 1995). Furthermore, the D96N substitution was shown to be 
strongly associated with the cause of the emergence of G2 strains in Taiwan, Thailand, UK 
and Nepal (Doan et al., 2011, Iturriza-Gomara et al., 2011, Khamrin et al., 2007, Trinh et al., 
2010, Zao et al., 1999). This substitution may impart to the strains in this nascent lineage the 
potential to spread globally in the near future.  
In this regard, it may deserve to examine the amino acid substitution at position 96 of 
the VP7 gene in other common human rotavirus genotypes such as G1, G3, G4 and G9. In 
theory, the substitutions are more likely to occur between amino acids with similar 
biochemical properties and are therefore less likely to affect the function of protein. However, 
the G2 human rotavirus strains had a substitution at position 96 that occurred between a 
negatively charged polar amino acid (aspartic acid) and an uncharged polar amino acid 
(asparagine) with the most nucleotide changes occurring between G and A at position 334 in 
the nucleotide sequence; hence codon changes occurring between GAT and AAT, 
respectively (Arista et al., 2005, Doan et al., 2011, Gomara et al., 2001, Lazdins et al., 1995, 
Mascarenhas et al., 2010, Page and Steele, 2004a, Page and Steele, 2004b, Trinh et al., 2010, 
Zao et al., 1999). Therefore, this substitution probably contributed to a major antigenic change 
that may have helped abrupt increase or re-emergence of G2 rotavirus strains in many 
locations in the world. Interestingly, this radical substitution at position 96 between 
asparagine and aspartic acid also observed in G3 human rotavirus strains (Dyall-Smith et al., 
1986, Lazdins et al., 1995, Mackow et al., 1988, Nishikawa et al., 1989, Phan et al., 2007). 
The re-emergence in high frequency of G3 strains (95%) detected in Japan in 2003-2004 that 
was also associated with D96N substitution in antigenic site of the VP7 gene (Nishikawa et al., 
1989, Phan et al., 2007). In contrast, the G4 and G9 rotavirus strains only showed 
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conservative substitutions at position 96: T96N in G4 strains, and T96A, T96P in G9 strains 
(Coulson et al., 1996, Kirkwood et al., 1993, Teodoroff et al., 2005). The re-emergence of G4 
and G9 rotavirus strains associated with substitution at position 96 is unknown to date. The 
amino acid at position 96 of the G1 VP7 gene was conserved with glycine, except two G1 
strains in Argentina that showed a G96V substitution (Barril et al., 2013).  
One peculiar exception to the rule for sub-lineage IVa-1 was a strain detected in Nara 
Prefecture in 2009, 90096, which contained glycine at position 96. To the best of our 
knowledge, this is the first report of the G2 strain that had a substitution from asparagine to 
glycine at position 96 of the G2 VP7 protein. Thus, it is tempting to speculate that once the 
90096 strain adapted to the human population, the N96G substitution would likely be fixed as 
it occurred in the G1 VP7 proteins.  
Strains with the G2P[4] genotype have captured recent attentions because of its abrupt 
increase or re-emergence in many locations in the world including where the universal mass 
rotavirus vaccination program was implemented. In this study, we found one G2 strain 
(B100056) belonging to sub-lineage IVa-3 in Japan. The sub-lineage IVa-3 is a contemporary, 
globally dominant lineage. In Brazil, it appears that there was a shift of sub-lineage from IVa-
1 to IVa-3 after rotavirus vaccine introduction (Matthijnssens et al., 2011). However, in Japan, 
we found a G2 rotavirus strain of sub-lineage IVa-3 before rotavirus vaccine introduction. 
Thus, it was hypothesised that the shift from sub-lineage IVa-1 to IVa-3 was due to natural 
genotype variation and that it was facilitated by the introduction of rotavirus vaccine.  
When the proportion of G2P[4] genotype was analysed in the context of the G and P 
genotype distribution in Japan, there was a significant increase of G2 strains from 7.4% in 
1988-1989 to 25% in 1989-1990, then a sharp increase to 87% in 1990-1991 (Nakagomi and 
Nakagomi, 2009). However, the increase in frequency of G2 strains in Japan in the 1990-1991 
was not associated with the D96N substitution in the antigenic sites of the VP7 gene. Changes 
in genotypic patterns within a population may be explained by the interplay between the 
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population’s immunity and viral evolution. New highly infective viral strains may only 
disappear when populations reach herd immunity (Kobasa et al., 2004). So the sharp increase 
of Japanese G2 strains in 1990-1991 may be due to the population immunity.  
In the viral evolutionary aspect, this study was only provided the evolution of G2VP7 
genes. Thus, it would also be interesting to examine the genetic evolution of other genome 
segments to investigate whether viral evolution were involved in the sharp increase of 
Japanese G2 rotavirus strains in 1990-1991. 
3.2. A rare G1P[6] super-short human rotavirus strain carrying an H2 genotype on the 
genetic background of a porcine rotavirus 
 Nearly-full genome sequencing disclosed that human rotavirus strain AU19 isolated 
from a Japanese infant with severe gastroenteritis possessed an unusual G1- P[6]- I5- R1- C1- 
M1- A8- N1- T1- E1- H2 genotype constellation that has never been described before. The 
possession of the I5 and A8 genotypes strongly suggests that the original host of AU19 was 
the pig species. Since human rotaviruses carrying the Wa-like genotype constellation share 
the same genotype with porcine rotaviruses in several genome segments (Matthijnssens et al., 
2008a), it is essential to examine what lineage AU19 clustered into to estimate the host 
species origin of the genome segments of AU19. Other than the VP6 and NSP1 genes for 
which the porcine origin was clear at the genotype level, seven genome segments of AU19 
was determined most likely to be of porcine rotavirus origin: the VP7, VP4, VP1, VP2, VP3, 
NSP3, and NSP4 genes that carried the G1, P[6], R1, C1, M1, T1, and E1 genotypes, 
respectively. The host species origin of the NSP2 gene (the N1 genotype) was not determined 
conclusively due to the paucity of sequence information; however, the porcine rotavirus origin 
of this genome segment was not excluded, either. Overall, the genetic background of AU19 
was of porcine rotavirus origin, and the parental porcine rotavirus was likely to have acquired 
the H2 NSP5 gene by genetic reassortment with a co-circulating human super-short strain 
when the parental virus changed its host from pigs to humans.  
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 Pigs are often considered as the host species from which rotaviruses crossed the 
species barrier into humans; at least 27 strains were recorded in the literature whose genome 
was fully sequenced (Banyai et al., 2009a, Degiuseppe et al., 2013, Esona et al., 2009, Ghosh 
et al., 2012a, Heiman et al., 2008, Komoto et al., 2013, Matthijnssens et al., 2008a, 
Matthijnssens et al., 2011, McDonald and Patton, 2008, Mladenova et al., 2012, Mukherjee et 
al., 2011, Mullick et al., 2013, Papp et al., 2013a, Varghese et al., 2004, Varghese et al., 2006, 
Wang et al., 2010, Zeller et al., 2012). While BE2001, Ryukyu-1120 and mani362/07  
(Komoto et al., 2013, Mukherjee et al., 2010, Zeller et al., 2012) are examples of direct 
transmission of porcine rotaviruses as a whole genome, the majority of porcine-like human 
rotavirus strains represent interspecies transmission involving genetic reassortment. AU19 
together with strains like Arg4605, mani253/07, mcs/13-07, and BP1901 belonged to the 
latter category in which interspecies transmission occurred in the form of genetic reassortment 
(Degiuseppe et al., 2013, Mukherjee et al., 2010, Papp et al., 2013a) (Table 2.2). While there 
appears no clear trend regarding which genome segments preferentially derived from human 
rotaviruses, it is only AU19 that carried an H2 genotype among all porcine-like human 
rotavirus strains reported to date (Table 2.2). 
 The H2 genotype has never been linked to any animal rotaviruses and has so far been 
detected only in human rotaviruses (Fig.2.15). In addition, the H2 genotype is further divided 
into H2a and H2b genotypes, each of which is carried by strains possessing short or super-
short electropherotypes, respectively (Ghosh et al., 2013). Both electropherotypes are known 
to contain longer 3’ non-coding sequences than long electropherotypes, and may occur for 
human rotavirus strains with the H1 genotype as exemplified by BE2001 (Zeller et al., 2012) 
and Mc345 (Ghosh et al., 2012b) as well as human strain with the H3 genotype: B4106 
(Matthijnssens et al., 2006). The mechanisms by which prolonged 3’ non-coding sequences 
were generated are not completely understood, but at least two mechanisms have been 
proposed (Matsui et al., 1990). One is a duplication starting from an internal coding sequence 
until the near the 3’ end of the gene, which explains the generation of the rearranged NSP5 
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gene of BE2001, Mc345, and B4106 (Kojima et al., 1996, Matthijnssens et al., 2006, Zeller et 
al., 2012). The other mechanism is less well understood but was proposed to involve 
polymerase stuttering. This latter mechanism is believed to generate short and super-short 
strains of the H2 genotype (Matsui et al., 1990). It has been pointed out that the NSP5 genes 
of DS-1 and 69M shared similar ancestral lineages (Matsui et al., 1990). However, more 
recently, it was reported that a small percentage of rearranged forms of the NSP5 gene can be 
produced in the course of acute rotavirus infection of immunocompetent children by the same 
mechanism as the partial duplication was generated for BE2001 (Schnepf et al., 2008). Thus, 
it could be possible that partial gene duplication occurred in the a shared common ancestral 
NSP5 gene of short and super-short strains, and random point mutations accumulated over 
time, making it impossible for the original sequence to be traced. 
 The NSP5 gene of AU19 clustered together with that of 69M, 57M and B37 with a 
bootstrap probability of 94% (Fig.2.15). The lineage that contained AU19 and the other three 
super-short human strains possessing the H2 genotype (H2b genotype) clustered with the 
lineage to which short strains belonged (H2a genotype) only with a marginal bootstrap 
probability of 69%. Inclusion of the sequence of the long 3’ non-coding region into the 
phylogenetic analysis however increased the bootstrap value to an 87% at the branching point 
into the short and super-short lineages whereas it did not change the tree topology (Fig.2.16). 
Assuming that the H2a and H2b genotypes have a common ancestor and that the evolutionary 
time is roughly proportional to the genetic distance, it is worthy of pointing out that the pair-
wise distance, an approximation of the genetic diversity, within the H2a genotype (0.2 - 4.4%) 
was as diverse as that within the H2b genotype (0-4.6%), suggesting that the time elapsed for 
the sequences to diversify within each sub-lineage was similar. If this speculation is correct, 
the observed difference in the relative frequency of short and super-short strains detected 
among sick children may suggest that short strains have more advantages in spreading among 
humans than super-short strains. An alternative possibility is that super-short strains may be 
maintained more frequently among asymptomatic children. 
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3.3. Evolutionary mechanisms of RVA strains through the molecular characterization 
studies 
 Rotaviruses are a large genetically diverse population of double-stranded RNA viruses 
which cause severe gastroenteritis in both humans and animals (Patton, 2012). The diversity 
of rotavirus is generated by several mechanisms: (i) accumulation of point mutation; (ii) 
reasorrtment that lead to the novel genetic and antigenic characteristics when two strains 
exchange the genetic materials; (iii) direct transmission of animal strains into a human host as 
the whole genome; (iv) gene rearrangement (e.g., deletions, insertions and duplications) 
(Gentsch et al., 2005, Kirkwood, 2010).  
 The previous study analysed by Doan et al. confirmed that the G2VP7 gene evolved in 
a fashion in which new lineages emerged within the previous dominant lineage (Doan et al., 
2011). In this study, the molecular evolution of Japanese G2 RVA strains during 31 year 
period (1980-2011) showed that the Japanese G2 VP7 genes correlated well with that of 
global strains. However, in this study, the new emergence of a nascent lineage was derived 
from the previous existing lineage which detected for the last time 18 years before. We 
hypothesised that during this period, strains in group IV except IVa circulated at a low 
frequency, accumulated point mutations over time and became emerged when acquiring the 
D96N substitution, a salient feature of the lineage IVa strains that have prevailed since the last 
decade.  
 AU19 strain is likely to be assumed to have emerged as a consequence of two sets of 
events, interspecies transmission of a porcine rotavirus to a child, coupled with acquisition of 
a rare rearranged NSP5 gene (H2b genotype) by genetic reassortment probably from a co-
circulating human rotavirus strain. Adding AU19 strain into the H2b genotype made the 
genetic diversity of H2b genotypes as diverse as that of the H2a genotype, lending support to 
the hypothesis that super-short strains carrying H2b genotype have long been circulating 
unnoticed in the human population. Two rare events occurred in AU19 strain provided the 
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hypothesis that the AU19-like strains had been circulating in human population for a long 
time. The strains did not die out after being transmitted as in the case of the direct 
transmission from porcine into human hosts as a whole genome. AU19-like strains were 
likely to be adapted to the human population by the acquisition of the H2b gene through 




CHAPTER 4. CONCLUSIONS 
 
The conclusions drawn from the molecular characterisation of Japanese RVA strains 
analysed in this thesis are twofold.  
Firstly, the genes of RVA strains are likely to evolve in nature through the 
accumulation of point mutations resulting in the emergence of a new lineage in a stepwise 
fashion. While it was previously stated that the G2VP7 gene evolved in a dynamic fashion 
such that new lineages emerged within the previously dominant lineage, one of which became 
subsequently dominant (Doan, et al., 2011), a new lineage can emerge outside of currently 
dominant as exemplified by the nascent lineage in the G2 VP7 gene. The potential for a new 
lineage to spread and become dominant lineage may be associated with the acquisition of the 
D96N substitution. As the nascent lineage carries this hallmark substitution of D96N, close 
monitoring is worthy. 
 Secondly, interspecies transmission of animal RVA to humans (and subsequent 
genetic reassortment) is likely to have played an important evolutionary role, when succeeded 
in establishing a human-to-human transmission chain, as exemplified by a rare porcine-like 
human RVA strain AU19. However, the case of AU19 appears to have ended in dead-end 
infection rather than establishing a successful human-to-human transmission chain.  
However, it remains to be seen whether the accumulation of point mutations will be 
accelerated and interspecies reassortant strains will have a survival advantage over co-
circulating human RVA strains under selective pressures imposed by wide-spread use of 
vaccines. Further studies are, therefore, warranted to monitor at the full-genome level if such 
emerging strains will spread globally in order to ensure the successful use of vaccines  and to 
explain the vaccine failure if it occurs.  
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CHAPTER 5: LITERATURE REVIEW 
 
Rotaviruses belong to the genus Rotavirus within the family Reoviridae causing the 
severe acute gastroenteritis in infants and young children worldwide. Rotaviruses share the 
common morphological and biochemical properties as described as Estes and Greenberg 
(Estes and Greenberg, 2013). 
- The mature virus particles are about 100 nm in diameter including the spikes, relative 
large for a non-enveloped virus. The particles possess a triple-layered icosahedral protein 
capsid: an outer layer, an intermediate layer, and an inner core layer.  
- The particles contain an RNA-dependent RNA polymerase and other enzymes capable 
of producing capped RNA transcripts. 
- The virus genome contains 11 segment dsRNA in which the genetic assortment can 
occur during the infection with rotaviruses. 
- Virus replication occurs in the cytoplasm of infected cells. 
- Virus cultivation in vitro is facilitated by treatment with proteolytic enzymes because 
the outer capsid spike polypeptides are cleaved to enhance viral infectivity. 
5.1. History of rotavirus discovery 
Rotavirus was detected in human from an Australian child in 1973 for the first time in 
electron micrograph of thin section of duodenal mucosa and later by electron microscope 
(EM) in faeces (Bishop et al., 1973) just 1 year after the discovery of Kapikian et al. about 
Norwalk virus from the gastroenteritis outbreak in 1972. Soon after the discovery of rotavirus, 
a number of reports about the rotavirus as the important aetiology causing gastroenteritis all 
over the world increased day by day. However, rotaviruses were described in animals in the 
1960s which were later confirmed by sharing the morphology and the group antigen with 
human rotaviruses (Estes and Greenberg, 2013, Flewett et al., 1974b).  
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5.2. Description and classification 
5.2.1. Morphology 
The morphology of rotavirus particles is very distinctive with a short spokes surround 
the hub of the wheel (the Latin word, rota, means wheel). Under the cryo-electron microscopy, 
the complete rotavirus virion is the triple-layered particle penetrated by 132 channels and has 
60 spikes on its surface (Flewett et al., 1974a, Flewett et al., 1974c).  
- The smooth surface of the outer layer formed by viral protein (VP) 7 from which sixty 
protein spikes formed by VP4 rise out. 
- The middle layer formed by VP6, the most abundant protein of the virus particles, and 
it specifies for rotavirus serotype. 
- The innermost layer consists of VP1, VP2, and VP3 which packed the viral genome of 
rotavirus.  
 
Fig. 5.1. Negative-stained electron micrograph of rotavirus particles in a faecal specimen. 






5.2.2. Genome and gene-coding assignments 
The viral genome of 11 segments of dsRNA is surrounded by the three concentric 
layers of protein. The genome encodes six structural viral proteins (VPs) and six non-
structural protein (NSPs), each genome segment codes for a single viral protein except NSP5 
gene which codes two proteins (NSP5 and NSP6) (Estes and Greenberg, 2013).  
 
  
Fig.5.2. Three and two dimensional structure of the mature rotavirus particle derived from 
cryo-electron microscopy images and computer image processing. (Courtesy of T.T.Nguyen, 
National Institute of Hygiene and Epidemiology, Vietnam) 
RNA segments 1, 2 and 3 code for the inner core protein VP1, VP2 and VP3, 
respectively which plays the important roles in segment packing and RNA interaction and 
replicase activity (Estes and Greenberg, 2013). RNA segment 6 codes the middle layer protein, 
which carries specific- group and subgroup epitopes. VP7, encoded by RNA 7, 8 or 9, 
depending on the strain and VP4, encoded by RNA 4 formed the outer capsid, the outmost 
layer. VP4 is cleaved into VP8* and VP5* subunit by protease that is essential for the 




The segments RNA 5, 6, 8, 9, 10 and 11 encoding for the six non- structural proteins, 
NSP1, NSP 2 and NSP3 (depending on the strain), NSP4, NSP5 and NSP6. These non- 
structural proteins have many functions on the virus replication cycle, especially in 
morphogenesis.  









1 VP1 RNA-dependent RNA polymerase, ss 




2 VP2 RNA binding, required for replicase 
activity of VP1 
Core protein C1 - C9 
3 VP3 Guanyltransferase, methyltransferase, 
ss RNA binding, complex with VP1 
Methyltransferase M1 - M8 
4 VP4 P-type neutralisation antigen, viral 
attachment, homotrimer, protease-
enhanced infectivity, virulence, 
putative fusion region 
Protease sensitive P[1] – 
P[37] 
5 NSP1  Interferon antagonist, putative viral E3 




6 VP6 Subgroup antigen, trimer, protection, 
required for transcription 
Inner capsid I1-I16 
7 NSP3 Acidic dimer, binds 3’end of viral 
mRNAs, cellular elF4G, Hsp90, 







8 NSP2 Basic, octamer, RNA binding, 
NTPase, NDP kinase 
NTPase N1-N9 
9 VP7 G-type neutralisation antigen, 
glycoprotein calcium dependent trimer 
Glycosylated G1-G27 
10 NSP4 RER transmembrane glycoprotein, 
viroporin, intracellular receptor for 
DLPs, role in morphogenesis of TLPs, 
interacts with viroplasms and 
autophagy pathway, modulates 
intracellular calcium and RNA 
replication, enterotoxin secreted from 
cells, virulence 
Enterotoxin E1-E14 
11 NSP5 Basic, phosphoprotein, RNA binding, 
protein kinase, forms viroplasms with 
NSP2, interacts with VP2 and NSP6 
PHosphoprotein H1-H11 
 NSP6 Interact with NSP5, present in 
viroplasms and most virus strains, 
RNA binding 
  
ssRNA: single stranded RNA; mRNA, messenger RNA; PABP, poly(A)-binding protein; 
NTPase, nucleoside triphosphate; NDP, nucleoside diphosphate; RNPase, RNA triphosphate; 





5.2.3. Classification of rotavirus: 
Rotaviruses have been classified into seven groups from A to G (now classified 
taxonomically as Rotavirus A, Rotavirus B, Rotavirus C, etc. (RVA, RVB, RVC, etc) based 
on the antigenic properties of VP6 protein (Ball, 2005, Kohli et al., 1992). Among them, only 
groups A, B and C showed the evidence to associate with the human illness whereas group D, 
E, F and G commonly detected in animals (Ball, 2005, Martella et al., 2010). RVA, or 
Rotavirus A, is responsible for the vast majority of human rotavirus infections, especially 
children under 5 years of age. Group B rotavirus, or Rotavirus B, was detected was the 
aetiology of the diarrhoea outbreak in China, India and Bangladesh, Nepal (Ahmed et al., 
2004, Alam et al., 2013, Hung et al., 1987, Malik et al., 2011, Nakata et al., 1987, Sanekata et 
al., 2003). Group C rotavirus, or Rotavirus C, also causes occasional diarrhoea in children 
(Estes and Kapikian, 2007, Mitui et al., 2009).  
In RVA, rotaviruses were classified by (i) antigenic VP6, VP7 and VP4 into subgroup, 
G serotypes and P serotypes, respectively; (ii) genomic RNA electrophoretic patterns into 
electropherotypes; (iii) RNA- RNA hybridization patterns into genogroups and nucleotide 
sequence of genome segment into genotypes. 
VP6 protein, the most abundance protein, containing antigenic epitopes is the target 
for serological methods such as immunofluorescent, enzyme-linked immunosorbent assay 
(ELISA), and immune electron microscope (IEM) (Estes and Greenberg, 2013). Based on the 
antigenic epitopes of VP6 protein, RVA strains are classified into subgroups I and II, I+ II, 
and nonI/ nonII but human rotaviruses A mainly belonged to subgroup I and II (Estes and 
Greenberg, 2013).  
The dsRNA can be extracted and separated easily by polyacrylamide gel 
electrophoresis. The different types from polyacrylamide gel electrophoresis are called 
“electropherotype” with the “long”, “short” and super-short pattern. The various minor 
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differences in the migration of RNA segments have been detected and used in 
epidemiological study. The two prototype strains Wa and DS-1 represent two distinct RNA 
migration patterns: the long electropherotype with faster-migrating 10th and 11th genome 
segments and the short electropherotype with slower-migrating 10th and 11th genome 
segments (Kutsuzawa et al., 1982). What actually happened in short electropherotype, 
however, is the rearrangement of the 11th genome segment (coding for NSP5) by which this 
genome segment acquired an extra few hundred nucleotide insertion at their 3’ non-coding 
region; hence migrating slower than the original 10th genome segment (coding for NSP4) 
which in turn becomes the 11th genome segment as a consequence (Dyall-Smith and Holmes, 
1981). Rotavirus strains, albeit infrequently, may show super-short electropherotypes in 
which the rearranged 11th genome segment becomes even longer than that of short 




Fig. 5.3. Separation of rotavirus genomic RNA into 11 bands by polyacrylamide gel 
electrophoresis. Two RNA patterns, long and short, are represented by prototype strains Wa 
and DS-1, respectively. Strain A and B, both of short electropherotype patterns, differ only in 


























VP7 and VP4 carry neutralisation- specific epitopes are the targets of neutralizing 
antibody that define the virus serotype. VP7 is a glycosylated protein and the serotypes 
determined by this protein are termed G serotypes. Cleaved by protease, the VP4 determines 
the serotypes which are termed P serotypes. With the development of molecular biological 
techniques, serological assay are now being replaced by molecular typing and the term 
“rotavirus genotyping” came out. While there is a perfect correlation between G serotypes and 
G genotypes, there were some difference between G serotype and G genotype. Therefore, P 
genotype was being designated within a spare bracket in order to differentiate with P serotype. 
There are now 27 G and 37 P genotypes currently ratified by the Rotavirus Classification 
Working Group (RCWG) (Matthijnssens et al., 2009, Matthijnssens et al., 2011, Trojnar et al., 
2013) and they can produce a numerous of G and P combinations (Nakagomi and Nakagomi, 
2009). There are at least 74 G-P combination in the pre vaccine licensure period (Gentsch et 
al., 2005, Santos and Hoshino, 2005) and an additional 11 new G-P combinations found in 
human RVA strains including new antigen combination from sporadic cases for the 2007- 
2012 period, the post vaccine licensure period (Doro et al., 2014). However, the common 
combinations were limited to G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8] (Banyai 
et al., 2012, Doro et al., 2014, Gentsch et al., 2005, Kawai et al., 2012, Santos and Hoshino, 
2005).  
Another classification of rotavirus is defined by RNA- RNA hybridization with probes 
prepared from the prototype strains. From the first two genogroups, the Wa and DS-1 (Flores 
et al., 1982), after 6 years, AU-1 genogroup was added (Nakagomi et al., 1989). The strains in 
the same genogroup of human rotaviruses contain the corresponding genes (in which the Wa 
strain is the prototype, for examples) share extensive homology, but this degree of homology 
is not shared with strains belonging to the other genogroup (in which the DS-1 strain is the 
prototype) and reversely. Interestingly, the Wa and DS-1 genogroup correspond respectively 
to two distinct electropherotypes of viral RNA: long patterns (characterised by their faster-
moving 10th and 11th gene segments) and short patterns (slower-moving 10th and 11th gene 
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segments) (Nakagomi et al., 1988). Furthermore, short and long patterns were believed to be 
associated with subgroup I or II specificity, respectively until the identification of the AU-1 
strain that belongs to subgroup I yet has a long RNA pattern. Super-short pattern infrequently 
detected showed the rearranged 11th genome segment even longer than that of short pattern.   
 
G and P classification might miss the differences in the genotype constellation that 
only occur in the  internal capsid and non-structural protein genes where human rotavirus-
specific genotypes are replaced with unusual or animal rotavirus-specific genotypes. As more 
rotavirus strains were sequenced for the entire genome segments, there was an increasing 
need for expanding a similar classification system for every genome segment; thus, the 
RCWG was organised, and it adopted the classification system in which the genome of 




Fig. 5.4. Hybridization 
pattern obtained 
between genomic RNAs 
from various human 
rotavirus strains and the 
32P labelled plus 
strained RNA probe 
prepared from the Wa, 
DS-1 and AU-1 strains. 






Tx-Ex-Hx (“x” representing the genotype number) for denoting the VP7-VP4-VP6-VP1-VP2-
VP3-NSP1-NSP2-NSP3-NSP4-NSP5 genes, respectively (Matthijnssens et al., 2008a, 
Matthijnssens et al., 2011, Matthijnssens et al., 2008b). The three major genotype 
constellations are described as: G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 (Wa genogroup), 
G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2 (DS-1 genogroup) and G3-P[9]-I3-R3-C3-M3-A3-
N3-T3-E3-H3 (AU-1 genogroup) (Matthijnssens et al., 2011, Matthijnssens et al., 2008b). 
The numbers of 11 genome segments were listed in Table.5.1  
 
Table 5.2. Full-genome constellations of some human and animal RVA strains. “-” indicates 
that the genotypes is unknown. Interspecies transmitted RVA strains were not listed here as 
they are listed in Table 5.3. Blue, red, yellow and purple shades are used for segments 
belonging to the lineage constellation of the ancestor Wa, DS-1, AU-1 and PO-13 strains, 
respectively. Grey shades indicate other genotypes. 
  VP7 VP4 VP6 VP1 VP2 VP3 NSP1 NSP2 NSP3 NSP4 NSP5 
Wa Human G1 P[8] I1 R1 C1 M1 A1 N1 T1 E1 H1 
KU Human G1 P[8] I1 R1 C1 M1 A1 N1 T1 E1 H1 
DS-1 Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2 
KUN Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2 
AU605 Human G2 P[4] I2 R2 C2 M2 A2 N1 T2 E2 H2 
NT015 Human G1 P[8] I2 R2 C2 M2 A2 N2 T2 E2 H2 
AU-1 Human G3 P[9] I3 R3 C3 M3 A3 N3 T3 E3 H3 
WC3 Bovine G6 P[5] I2 R2 C2 M2 A3 N2 T6 E2 H3 
Gottfried Porcine G4 P[6] I5 R1 C1 M1 A8 N1 T1 E1 H1 
OSU Porcine G5 P[7] I5 R1 C1 M1 A1 N1 T1 E1 H1 
PO-13 Avian G18 P[17] I4 R4 C4 M4 A4 N4 T4 E4 H4 
RRV Simian G3 P[3] I2 R2 C3 M3 A9 - T3 E3 H6 
FRV-1 Feline G3 P[9] I3 R3 C3 M3 A3 N3 T3 E3 H3 
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FRV-64 Feline G3 P[3] I3 R3 C2 M3 A9 N2 T3 E3 H6 
02V00-
002G3 
Chicken G19 P[17] I4 R4 C4 M4 A4 N4 T4 E4 H4 
10V01- 
12H5 
Phesant G23 P[37] I4 R4 C4 M4 A16 N4 T4 E4 H4 
 
5.3. Epidemiology 
5.3.1. The global burden of rotavirus 
Diarrhoea is one the most important issues causing high morbidity and mortality in 
children, especially are under 5 years old. In 2003, among 6 causes which attributed to 73% 
deaths in children younger than 5 years old, diarrhoea was the secondary, accounted for 18% 
(including 17% deaths in children 1- 59 months and 3% in neonatal deaths), just after 
pneumonia (19%) (Bryce et al., 2005). 
Among all diarrhoeal causes, rotavirus is the leading cause of severe gastroenteritis in 
infants and young children worldwide (Parashar et al., 2009, Tate et al., 2011). According to 
the data from WHO rotavirus surveillance network, the medians detection of rotavirus in 
  
Fig.5.5. Worldwide mortality in neonates and children under 5 years old (adapted from 
(Parashar et al., 2003). Left panel. Worldwide causes of neonatal deaths; Right panel. 
Worldwide causes of death in children under 5 years of age 
54 
 
hospitalised children were 40% in 2010 and 39% in the period from 2000- 2004 (WHO, 2011). 
Of estimated 1,566,000 childhood diarrhoea deaths in 2002, rotavirus caused approximately 
611,000 childhood deaths (IQR 454,000- 705,000) and more than 80% of all rotavirus-related 
deaths were estimated to occur in low-income countries of South Asia and sub-Saharan Africa 
(Parashar et al., 2006). Worldwide in 2008, diarrhoea attributable to rotavirus infection 
resulted in 453 000 deaths (95% CI 420 000–494 000) in children younger than 5 years old 
and 37% of deaths attributable to diarrhoea and 5% of all deaths in children younger than 5 
years old (Tate et al., 2011). 
5.3.2. Molecular epidemiology of human RVA 
Before 2005, the five most common G and P combinations were G1P[8], G2P[4], 
G3P[8], G4P[8] and G9P[8] represented over 92% of the strains analysed globally (Gentsch et 
al., 2005, Santos and Hoshino, 2005). After 2005, I reviewed the global distribution of G and 
P genotype and noticed that, from 2005 to 2011, G1P[8] genotype was still the most prevalent 
one which accounted for more than one third of all combinations (39.4%). The other four 
common combinations were G9P[8], G2P[4], G3P[8] and G4P[8] (15.5%, 14.2%, 12.6% and 
5.1%, respectively). The five common combinations accounted for 87% of all G and P 
combinations. The other combinations including several novel G types and P types comprised 
about the rest of 13% of the total. Global distribution of G2 RVA strains did not change much 
over time, from 14.1% before 2004 to 15.3% after that. However, there was a big change in 
G9 RVA strains frequency, from 5.8% through the end of 2001 and 5% before 2004 (Gentsch 
et al., 2005, Laird et al., 2003, Santos and Hoshino, 2005) and increased to 19.1% in the 
period 2005 - 2011 and became the secondary common genotype after G1 genotype. In the 
future, G9 strains may need to be included in the vaccine because of the quick global spread 
(Tcheremenskaia et al., 2007). The first G12 strain isolated in Philippine in 1987. After 10 
year unable to detect, it increased rapidly worldwide, from 0.1% before 2004 to 1.5% after 
that. Recently, in the post vaccine licensure surveillance, G12P[8] strains were accounted for 
2.7% of all specimens collected in the countries where rotavirus vaccines were introduced. 
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G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8] were still the most five common G and P 
combination (31.2%; 13.0%, 10.7%, 4.0% and 10.2%, respectively). Together with G12P[8] 
strains (Doro et al., 2014), these six G and P combination strains were found in 73% of the 






The genotype distributions were favourable patterns in each continent and country. 
In Europe and North America, G1P[8] was predominant (47.9% and 59.7%, respectively), 
In Australia and South America, the highest frequency was G2P[4] genotype (27.9% and 
39.3%, respectively) and that in Asia was G3P[8] genotype. In Africa, although G1P[8] 
strains were predominant, other combinations such as G9P[8], the frequency of G1P[6] 
strains were higher than in other continents. After vaccine introduction, predominance 
circulation of G1P[8] strains was found in most of regions except Americas where G2P[4] 
strains were relatively more commonly reported (Doro et al., 2014).  
Before 2005, in Africa, the relative frequency of G8 was as high as that o the global 
common G3 or G3; P[6] represented for almost one-third of all P types identified; RVA 
strains bearing unusal combinations were accounted for 27% of rotavirus infection (Santos 
and Hoshino, 2005). After vaccine introduction in Africa, P[6] RVA strains continued to 
circulated at marked prevalence (Doro et al., 2014).  
 
  
2004- 2011 (not published) 2001- 2008 (adapted from 
(WHO, 2011)) 
1989- 2004 (adapted from 
(Santos and Hoshino, 2005)) 
Fig.5.6. Global distribution of G-P combinations of RVA strains in diferent time periods.   
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In our review, G1 genotype strains accounted for 43%, followed by G9 genotype 
strains (17.0%), G2 (15.3%), G3 (12.6%) and G4 (9.5%). These five common rotavirus G 
types comprised about 97% of the total. G2 genotype became the most predominant 
genotype in South America (two times higher than that in North America and nearly 3 
times higher than that of global distribution). In Australia where two kinds of rotavirus 
vaccine was used in different regions, the follow- up study after vaccination showed that in 
the states using RotaTeq, G1P[8] was predominant, followed by G2P[4] while in the states 
using Rotarix, G2P[4] was predominant followed by G1P[8] (Kirkwood et al., 2011, 
Kirkwood et al., 2009, Snelling et al., 2011). On the other hand, G2P[4] genotype in 
Europe is nearly same in frequency before and after 2004 (Santos and Hoshino, 2005) and 
similar in the vaccine and non-vaccine regions (Antunes et al., 2009). These data supported 
a strong evidence of the fluctuant circulation of G2P[4] rather than vaccine induced 
selection (Iturriza-Gomara et al., 2009). In South America, especially Brazil, G2P[4] 
became the most predominant genotype or circulated as the only genotype that could find 
after the introduction of Rotarix vaccine (Borges et al., 2011, Correia et al., 2010, Gomez et 
al., 2011, Luchs et al., 2011, Vieira et al., 2011). However, several studies indicated that 
G2P[4] and G2P[NT] was not homogeneous throughout Brazil (Leite et al., 2008). In 
addition, G2P[4] was also the predominant genotype in the neighbouring countries where 
rotavirus was not available (Esteban et al., 2010, Martinez et al., 2010). Taking together 
with the high efficacy of Rotarix against G2P[4] (77%) (Justino et al., 2011) showed the 






Fig.5.7. Distribution of G-P combinations of human RVA strains by continents/sub-
continents, 2005 - 2011 (unpublished) 
  
5.3.3. Rotavirus transmission  
Rotaviruses are transmitted by the faecal-oral route. The circumstance whether 
rotaviruses are transmitted also by the respiratory route was not well proven yet. However, 
there were some evidences for this circumstance are: the rapid acquisition of rotavirus 
antibodies in the first few years of life, regardless of hygiene standards; a few large 
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outbreaks in which a faecal - oral spread could not be documented; the occurrence of 
respiratory symptoms in a proportion of patients with rotavirus gastroenteritis.  
The resistance to physical inactivation (along with the large number of viral 
particles shed in faeces) and long-life outside of the host may contribute to the efficient and 
rapid transmissions of the human rotaviruses. Although rotaviruses have been detected in 
raw or treated sewage, it is unlikely that contaminated water (which is very important in 
RVA outbreaks) plays an important role in transmission of RVA strains.  
 High relative humidity (about 80%) results to a rapid loss in human rotavirus 
infectivity. Effective disinfection of contaminated material and careful hand-washing 
constitute important measures to contain rotavirus infection, especially in hospital and 
school. 
5.4. Immunity 
Rotaviruses often cause symptomatic infection in children from 3 months to 2 years 
of age. Severe diarrhoea likely occurs in the children from 3 to 24 months of age than other 
age group. In infants, natural rotavirus infection confers protection against subsequent 
infections and this protection accumulates after new infection and help to reduce the 
severity of the diarrhoea (Velazquez et al., 1996). 
The mechanisms responsible for immunity to rotavirus infection and illness are not 
completely understood, especially in humans. However, some observations suggested that 
antibodies in the lumen of the small intestine were the primary determinant of resistance to 
rotaviruses, whereas circulating serum antibodies failed to protect (Estes and Kapikian, 
2007). After a mucosal humoral and cell-mediated immune response, viruses are cleared 
within 1 week. Rotavirus-specific immunoglobulin A (IgA) antibodies on the enteric 
mucosal surface are thought to mediate protective immunity. Infection with one serotype 
provides serotype-specific (homotypic) protection, and repeated infections lead to partial 
cross- serotype (heterotypic) protection (Cunliffe and Nakagomi, 2007).   
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5.5. Clinical feature: 
The incubation period of rotavirus diarrhoeal illness has been estimated to be less 
than 48 hours. The incubation period of the illness under the experiment conditions was 1 
to 4 days (Estes and Kapikian, 2007). 
Fever, vomiting and watery diarrhoea are the most common symptoms observed in 
the infected children (Cunliffe and Nakagomi, 2007). These symptoms normally last within 
one week. The temperature is 37.9oC or above. Rotavirus diarrhoea starts later than 
vomiting but lasts longer (Rodriguez et al., 1977). Death occurs within 1 or 2 days of onset 
of symptoms. The major factor causing death is believed to be dehydration and electrolyte 
imbalance and seizures is a contribution factor (Carlson et al., 1978). Rotavirus can produce 
a chronic symptomatic infection in immunodeficient children. During chronic infection, 
rotavirus can undergo rearrangements in its genome, leading to abnormal electrophoretic 
migration patterns of rotavirus RNA (Desselberger, 1996, Hundley et al., 1987). Because 
rotaviruses are also found in the organ outside the intestine, such as respiratory tract, liver, 
central nervous system and kidney, the symptoms of these organs infections are recorded in 
the rotavirus infection children. There is limited evidence to show that the severity of the 
illness is related to the serotype.   
The clinical manifestations of rotavirus illnesses are not typical enough to diagnose 
on this basis alone. Therefore, the diagnosis needs to base on the laboratory results 
including detection of virus appearance and serological response. Stool specimens collected 
during the first four days after the onset is sufficient for virus detection but stool specimen 
can be collected up to 3 weeks after the onset depending on the duration of symptoms. 
Electron microscope that visualizes the virus particle directly has the advantage of high 
specificity because of the distinct morphologic appearance. ELISA assay which detect 
rotavirus antigen can solve the disadvantages of electron microscopy because of high 
sensitivity, simple requirement in equipment as well as availability of commercial kits. 
There are also some other techniques for virus detection such as counter-electro-
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osmorphoresis, gel electrophoresis, reverse passive hemagglutination assay, latex 
agglutination, dot hybridization assay and chromatography. However, RT-PCR and 
realtime RT-PCR becomes the most applicable and common techniques used in rotavirus 
diagnosis, which is 100,000 times more sensitive than the standard electropherotype 
method and 5,000 times more sensitive than hybridization.  
To measure a serological response to rotavirus infection, there are a variety of 
techniques such as immunological EM, complement fixation (CF) tests, immunofluorescent 
assay, immune adherence hemagglutination assay, ELISA to detect antibody, neutralisation, 
hemagglutination inhibition, inhibition of reserve passive hemagglutination, enzyme – 
linked immunospot (ELISPOT) assay and ummuno-cyto-chemical staining assay (Ishida et 
al., 1997, Kapikian, 1993, Shaw et al., 1992).  
Until now, there are not many effective treatment methods for most virus infections 
in general and rotavirus infection is no exception. The priority treatment is replacement the 
fluid and electrolytes lost by vomiting and diarrhoea. Intravenous fluid showed the high 
efficacy in treating dehydration from diarrhoea for many years and oral fluid replacement 
therapy also useful in the place that intravenous fluid is unavailable. A variety of 
formulation for oral rehydration salt (ORS) solutions has been developed and showed the 
high efficacy in the treatment of dehydration due to rotavirus diarrhoea. Glucose- based, 
sucrose- based and rice- based solutions are compared to each other to see the effect and all 
of them show the great archive in decreasing the stool output, increasing the absorption and 
retention of fluid and electrolytes.  
Human milk, containing rotavirus antibodies, has been used successfully for 
treatment of children who are immune-deficient with chronic rotavirus infection and illness 





5.6. Prevention and control 
5.6.1. Rotavirus vaccines 
Realising the burden of rotavirus on the medical care and society, scientists have 
being exerted to produce an effective and safe vaccine to protect human, especially children, 
from severe diarrhoea caused by rotavirus. After the first licensed vaccine RotaShield™ 
was withdrawn because of a side effect, many clinical trials for the new vaccine were 
conducted with the hope on finding an ideal vaccine. Two globally-licensed rotavirus 
vaccines, Rotarix ™ (GlaxoSmithKline Biologicals, Rixensart, Belgium) and RotaTeq™ 
(Merck & Co., Whitehouse Station, USA) have been recommended by the WHO for 
inclusion into national immunization programmes (WHO, 2009). RotaRix is a monovalent 
vaccine containing human G1P[8] strain (RIX4414) (Vesikari et al., 2004). RotaTeq is a 
pentavalent vaccine that comprises 4 reassortant rotaviruses express the VP7 protein (G1, 
G2, G3 or G4) from the human rotavirus parents and the attachment protein P7[5] from 
bovine rotavirus parent strain; the fifth reassortant virus expresses the attachment protein 
P1A[8] from the human rotavirus parent strain and the outer capsid protein G6 from the 
bovine rotavirus parent strain (Desselberger, 2005). The vaccine trials and observational 
studies showed that Rotarix and RotaTeq were found to be safe, highly immunogenic and 
elicit both homotypic and heterotypic protections (Breiman et al., 2012, Kawamura et al., 
2011, Li et al., 2014, Linhares et al., 2011, Phua et al., 2009, Steele et al., 2012, Tregnaghi 
et al., 2011, Velasquez et al., 2014, Vesikari et al., 2010, Vesikari et al., 2007, Vesikari et 
al., 2006). These two vaccines also have shown their impacts on the reduction of mortality 
and morbidity due to severe diarrhoea (Bar-Zeev et al., 2015, Esparza-Aguilar et al., 2014, 
Gurgel et al., 2014, Macartney et al., 2011, Plosker, 2010, Richardson et al., 2011, Tate and 
Parashar, 2011). 
It is also known that the efficacy of either vaccine in developing countries is 
consistently lower than in developed countries; the efficacy of RotaTeq against severe 
rotavirus gastroenteritis during the first year of life was 51.0% in Asia and 64.2% in Africa 
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(Armah et al., 2010, Zaman et al., 2010). Recently, a monovalent vaccines derived from the 
human neonatal strain 116E was developed in India (Rotavac, Bhara Biotech International). 
The vaccine strain was natural reassortant strain G9P[11] with P[11] gene from bovine 
RVA strain (Bhandari et al., 2014a, Bhandari et al., 2014b). Another live-attenuated 
vaccine (Rotavin-M1) containing a human G1P[8] rotavirus strain (KH0118-2003) was also 
developed in Vietnam (POLYVAC) (Dang et al., 2012).  
While post-licensure studies detected a small and statically significant risk of 
intussusception associated with the administration of Rotarix, the conclusion is given that 
Rotarix is safe to administer to infants between 6- 12 weeks of age for the first dose and by 
24 weeks of age for the second dose. However, the authors strongly discourage the delayed 
administration of the first dose between 13 to 20 weeks of age, which is allowed without 
any warning (Nakagomi, 2011).  
5.6.2. Passive immunisation 
After many experiments, passive immunisation has been shown to be effective in 
preventing rotavirus illness in animals (Ebina, 1996, Hammarstrom, 1999, Sarker et al., 
1998). The studies carried out in human have not had results yet. However, passive 
immunisation is not practical for protection against rotavirus illness in humans, except for 
some special circumstances such.  
5.7. Antigenic and genetic diversity of G2 VP7 genes  
The VP7 protein is an abundant capsid protein and is usually encoded by genome 
segment 9 (Estes and Cohen, 1989). The nucleotide sequence predicts an open reading 
frame of 326 amino acids (Kozak, 1986). Nine variable regions (VRs) have previously been 
described that are homologous between the same G type but highly different across the 
specific serotypes (Gorziglia et al., 1990, Green et al., 1987, Nishikawa et al., 1989). Six of 
these regions are regarded as major antigenic regions (A-F): A (amino acid (aa) 87- 100), B 
(aa 141-150),  C (aa 208-224), D (aa 291), E (aa 190) and F (aa 235-242) (Coulson and 
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Kirkwood, 1991, Dyall-Smith et al., 1986, Estes and Cohen, 1989, Glass et al., 1985, 
Hoshino et al., 1994, Kirkwood et al., 1993, Lazdins et al., 1995, Mackow et al., 1988, 
Taniguchi et al., 1988).  
With the development of the advanced technologies in biology, the antigenic 
epitopes are mapped in the neutralisation domains of  the VP7 proteins based on the escape 
mutations selected by various neutralising monoclonal antibodies (mAbs) that recognise 
VP7 using the crystal structure of the rhesus rotavirus (RRV, G3) (Aoki et al., 2009, 
Dormitzer et al., 2004). These residues cluster into neutralisation domains 7-1a, 7-1b and 7-
2.  
 
Fig.5.8. Amino acid alignment of several human rotavirus A strains, simian strain (SA11) 
and vaccine strains in the neutralisation domains of VP7 gene. The numbering of amino 
acid residues is based on the RRV sequence. 
The VP7 sequence analysis of escaped mutants selected by G2 serotype-specific 
mAbs revealed that mutations at residue 94, 190, 201, 213 and 291 involved in virus 
neutralisation (Aoki et al., 2009, Dunn et al., 1993, Dyall-Smith et al., 1986, Higo-
Moriguchi et al., 2004, Lazdins et al., 1995, Morita et al., 1988, Raj et al., 1992). In 
addition, the nucleotide sequence analysis of VP7 of G2 rotaviruses revealed that the point 
mutations across the VP7 gene are related to the existence of 4 lineages: A87T, D96N, 
N213D, N242S (Doan et al., 2011). This study also showed that the G2 VP7 genes evolved 
in the dynamic fashion in which a new lineage emerged within the dominant lineage and 
replaced that to become the dominant lineage (Doan et al., 2011). The average time 
Name of strains 87 91 94 96 97 98 99 100 104 123 125 129 130 291 201 211 212 213 238 242 143 145 146 147 148 190 217 221 264
SA11/G3 T T N N S W K D Q N A V D K Q D A T D A K D A T L S E A G
Wa/G1 . . . G D . . . . . V . . . . N V D N T . . Q S . . M N .
DS-1/G2 A N S D E . E N . D N . N . . . V N N N R . N . S D I S .
KUN/G3 . N S D E . E N . D T M N . . . V N N S R . N . S D I S .
AU-1/G3 . . . . . . . . . . . . . . . . T N N N . . . . . . . . .
YO/G3 . . . . . . E . . . . . . . . . T N N N . . . . . . . . .
95H115/G9 . . G T E . . . . D . I . . . N T A . N . . S . . . . S .
L26/G12 N . T P D . T H . D . . N . . . V A N N Q Q N S . . . . .
T152/G12 S . T P D . T N . D . . . . . . V . N N Q Q N S . . . . .
Rotarix/G1 . . . G E . . . . S V . . . . N V D N T . . Q N . . M N .
RotaTeq-SC2-9/G2 A N S D E . E N . D T M N . . . V S N S R . N . S D I S .
RotaTeq-WI79-9/G1 . . . G D . . . . S V . . . . N V D N T . . Q S . . M N .
7-1a 7-1b  7-2
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between lineage divergence events in the G2 phylogenetic history is calculated to be 7 
years (Dennis et al., 2014). The mutation rates of G2 VP7 gene (1.45x10-3/site/year) is 
similar to that of G9 (1.87x10-3/site/year) strains and G12 (1.66x10-3/site/year) strains, 
which spread globally in less than a decade (Dennis et al., 2014, Matthijnssens et al., 
2010a). The gradual acquisition of point mutations in the VP7 gene has facilitated the 
expansion of G2 diversity during the last century (Dennis et al., 2014).  
5.8. Interspecies transmission of porcine rotaviruses to human hosts 
Rotaviruses are one of the viruses having a broad host range including mammalian 
and avian species. Although it is thought that host species of rotaviruses are restricted, an 
increasing number of novel rotavirus strains including several genotypes detected in 
humans which are believed to be of animal origin suggesting that interspecies transmission 
is one of the key factors for generating rotavirus diversity from the evolutionary context. 
Some of the most predominant genotypes (G3, G9 and G12) detected in humans are proven 
to be of animal rotavirus origin (Nakagomi and Nakagomi, 1989, Ghosh et al., 2006, 
Hoshino et al., 2005, Martella et al., 2010, Matthijnssens et al., 2006, Nakagomi et al., 1989, 
Teodoroff et al., 2005, Tsugawa and Hoshino, 2008). The epidemiological importance of 
these genotypes in the human population suggests that after crossing the host species 
barrier, they were adapted to the human hosts and then successfully spread globally. 
Rotaviruses are transmitted from animals to humans either as a whole virion or by 
genetic reassortment during co-infection (Nakagomi and Nakagomi, 1993, Nakagomi and 
Nakagomi, 2002). The reassortant formation is probably the most efficient when the co-
infecting strains are closely related to each other since the genome segments or the proteins 
they encode must function interchangeably. There is no reassortment between Rotavirus 
and Reovirus, both of which belong to Reoviridae. Similarly, no reassortment has been 














Fig.5.9. Reassortant process by which a new rotavirus strain was created. The reassortant 
strain carries the genome segment 4 and 7 from strain A and the remaining segments from 
strain B during the co-infection.  
 A number of studies provided evidence that direct transmission from RVA strains 
of ruminant or carnivore origin to humans are common (Banyai et al., 2009b, Doan et al., 
2013, Nakagomi and Nakagomi, 1991, Nakagomi and Nakagomi, 1989, Nakagomi et al., 
1989, Nakagomi and Nakagomi, 2000, Shirane and Nakagomi, 1994, Tsugawa and 
Hoshino, 2008, Wu et al., 2012). On the other hand, reports describing direct transmission 
of porcine rotaviruses  to humans are less frequently found probably because the close and 
intermingled genetic relationships between human and porcine RVA strains (Papp et al., 
2013a) make it sometimes difficult to clearly distinguish the true origin of the genome 
segment. The number of strains resulted from the direct transmission from porcine RVA 
strains is much smaller than that resulted from genetic reassortment. While BE2001,  
strain B 




Ryukyu-1120 and mani326/2007 were examples of direct transmission of porcine RVA 
strains as a whole genome, the majority of porcine-like human RVA strains involve in 
genetic reassortment (Table 5.3). RVA strains that carry human RVA genes in their porcine 
RVA genome may more transmissible in humans, thus, can be more readily circulated in 
patients causing gastroenteritis (Dong et al., 2013, Mladenova et al., 2012, Papp et al., 
2013a, Papp et al., 2013b).   
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Table 5.3. Human rotavirus strains transmitted from pigs by direct transmission or genetic reassortment and the origin of each 
genome segment. Blue, red shades indicate genome segments originated from human and porcine RVA strains. Grey shades 
indicate geome segments which the origins are indeterminable whether the origin is of porcine or human rotaviruses.  
Strain 
Place of 
detection VP7 VP4 VP6 VP1 VP2 VP3 NSP1 NSP2 NSP3 NSP4 NSP5 Reference 
GX54 China G4 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 
Dong et al., 2013 
CAU12-2 Korea G11 P[25] I12 R1 C1 M1 A1 N1 T1 E1 H1 
Jeong et al., 2014 
BP1901 Hungary G4 P[6] I1 R1 C1 M1 A1 N1 T7 E1 H1 
Papp et al., 2013a 
BP271 Hungary G4 P[6] I1 R1 C1 M1 A8 N1 T7 E1 H1 
Papp et al., 2013a 
Mc323 Thailand G9 P[19] I5 R1 C1 M1 A8 N1 T1 E1 H1 
Ghosh et al., 2012b 
BE2001 Belgium G9 P[6] I5 R1 C1 M1 A8 N1 T7 E1 H1 
Zeller et al., 2012 
Ryukyu1120 Japan G5 P[6] I5 R1 C1 M1 A8 N1 T1 E1 H1 
Komoto et al., 2013 
EC2184 Ecuador G11 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 
Banyai et al., 2009a 
RMC321 India G9 P[19] I5 R1 C1 M1 A8 N1 T1 E1 H1 
Varghese et al., 2006 
Arg4605 Argentina G4 P[6] I1 R1 C1 M1 A8 N1 T7 E1 H1 
Degiuseppe et al., 2013 
Arg4671 Argentina G4 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 
Degiuseppe et al., 2013 
IAL28 Brazil G5 P[8] I1 R1 C1 M1 A1 N1 T1 E1 H1 
Heiman et al., 2008 
Mani-97/06 India G9 P[19] I5 R1 C1 M1 A8 N1 T1 E1 H1 
Mukherjee et al., 2011 
Mani-253/07 India G4 P[4] I1 R1 C1 M2 A8 N1 T1 E1 H1 
Mukherjee et al., 2011 
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Mani-362/07 India G4 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 
Mukherjee et al., 2011 
mcs/13-07 India G9 P[6] I1 R1 C1 M1 A8 N1 T1 E1 H1 
Mukherjee et al., 2011 
R479 China G4 P[6] I5 R1 C1 M1 A1 N1 T7 E1 H1 
Wang et al., 2010 
KTM368 Nepal G11 P[25] I12 R1 C1 M1 A1 N1 T1 E1 H1 




CHAPTER 6: MATERIALS AND METHODS 
6.1. Specimens 
All the specimens analysed in this thesis were collected from children who admitted to 
hospitals for acute diarrhoea in Japan in the pre-vaccination era.  
In the first study, a total 35 G2 rotavirus strains that were analysed for their VP7 genes 
were in the collection of the archival stool specimens obtained from children with acute 
gastroenteritis in Akita or Yamagata Prefectures (two neighbouring prefectures in northern 
Japan) between 1983 and 2007, and the stool specimens obtained during the official 
surveillance activities at the Nara Prefectural Institute for Hygiene and Environment, Nara 
prefecture, Japan between 2008 and 2011.  
In the second study, the AU19 strain was originally detected in Akita, Japan in 1997 
from an infant with severe acute gastroenteritis (Nakagomi et al., 1999). 
6.2. RNA extraction and genome segment amplification 
The genomic RNAs which were extracted from a 10% suspension or cell culture fluid 
by using the QIAamp Viral RNA Mini Kit (QIAGEN Sciences, Germantown, MD, USA) 
according to the manufacturer’s instruction, and then reverse transcribed to cDNA by using 
SuperScript® III First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA) and random 
primers (Invitrogen).  
The cDNAs were used for the PCR reactions to amplify the genome segments using 
specific primers and the AcessQuick RT-PCR system (Promega Corporation, Madison, WI, 
USA). The VP7 genes of the Japanese G2 strains and the AU19 strain were amplified 
according to the method of Gouvea et al. (Gouvea et al., 1990) or  G2VP7-14F (5’- AGA 
ATT TCC GTC TGG CTA G - 3’) and  G2VP7-998R (5’- AAT GAT CTT GAC CGT TTG 
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GAC -3’) (designed for this study). The other genome segments of the AU19 strain were 
amplified with the specific primers described in Table 6.1. 
 
 Table 6.1.  The primers used to amplify the genome segments of the AU19 
Genome segment Primer name Primer sequence Reference 
VP1 GEN_VP1Fb 5'-GGC TAT TAA AGC TRT ACA 
ATG GGG AAG-3' 
Matthijnssens et 
al., 2008a 
 GEN_VP1Rb 5’-GGT CAC ATC TAA GCG YTC 
TAA TCT TG-3’ 
Matthijnssens et 
al., 2008a 
VP2 GEN_VP2Fc 5'-GGC TAT TAA AGG YTC AAT 
GGC GTA CAG-3' 
Matthijnssens et 
al., 2008a 




VP3 M1V3 – 22F 5’-AGT  GCG TTT TAC CTC TGA 
TGG – 3’ 
This study 
 M1V3_2591R 5'-GGT CAC ATC GTG ACT AGT 
GTG TTA-3' 
This study 
VP4 BegG4 5’-TGT ATC ATA CGG CTA TAA 
AAT G-3’ 
Isegawa et al., 
1992 
 EndG4 5'-TAA GGT TAT GTA TGG TCA 
CAT C-3' 
Isegawa et al., 
1992 










































NSP5 Beg11 5’-GGC TTT TAA AGC GCT ACA 
GTG ATG-3’ 
Giambiagi et al., 
1994 
 End11 5’-GGT CAC AAA ACG GGA 
GTG GG -3’ 
This study 
All the primers are located at the 5 ′ and 3′ends of the respective gene segments, except for 
primer GEN_VP2_Rbc, which starts at nucleotide 2, primer M1V3_22F, which starts at 
nucleotide 22. Degenerate bases: R=A/G, W=A/T, Y=C/T.  
6.3. Nucleotide sequence 
The amplified products were then purified using an ExoSAP-IT purification kit (USB 
Products, Affymetrix, Cleveland, OH, USA) according to the manufacturer’s instructions. 
Nucleotide sequencing reactions were performed by fluorescent dideoxy chain termination 
chemistry using the BigDye Terminator Cycle Sequencing Ready Reaction Kit, version 3.1 
(Applied Biosystems, Foster City, CA, USA), and then purified by using Sephadex. The 




6.4. Phylogenetic analysis 
The nucleotide sequences thus obtained were aligned using the Megalign program in 
the Lasergene 8 software package (DNAstar, Inc. Madison, WI, USA). Calculation of 
nucleotide sequence identities and phylogenetic analysis were performed by using MEGA 5 
(Tamura et al., 2011). The multiple sequence alignment was carried out using the 
CLUSTALW program, and the genetic distances between sequences were calculated by the 
Kimura two-parameter method. A phylogenetic tree was then constructed by using the 
neighbor-joining method. The bootstrap probability at a branching point was calculated with 
1,000 pseudo-replicate datasets. Four amino acids at positions 87, 96, 213 and 242 in the 
antigenic region of VP7 were chosen to define amino acid constellation. 
In the first study, we compiled the G2 VP7 nucleotide sequences that were determined 
in this study with those available in the DNA database by using the BLAST program 
(http://blast.ncbi.nlm.nih.gov/) with the DS-1 VP7 sequence as a query sequence. We 
increased the “Max target sequences option to 2000 to confirm to obtain all the BLAST hits. 
We retrieved more than 1000 sequences to include all possible G2 VP7 sequences, but used 
only sequences that had at least 615 nucleotides in length, spanning positions 307 and 921 
(corresponding to amino acid residues from 87 to 291). We removed either sequences of 
reassortant vaccine strains nor animal rotavirus strains. To distinguish sequences of rotavirus 
G2 strains with those of the other rotavirus strains, we preliminarily reconstructed a 
phylogenetic tree with more than 1000 sequences. Porcine G2-like strains are known to have 
the highest sequence similarities to human G2 strains among all RVA strains reported. We 
obtained 509 nucleotide sequences of human G2 strains of which 21 sequences were from 
human G2 strains detected in Japan. Among these Japanese human G2 sequences, the AU605 
was rotavirus strain culture-adapted from stool specimen 86A005, were used in this study. 
Thus, we excluded the AU605 sequence form the collection. Finally, a total 543 human G2 
sequences of which 35 G2 sequences determined in this study, 20 Japanese human G2 
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sequences from GenBank database and 488 other human G2 sequences from GenBank 
database were used for this study. 
In the second study, the genotype of each genome segment of AU19 was determined 
by using the RotaC2.0 automated genotyping tool for Rotavirus A (Maes et al., 2009). The 
phylogenetic trees were drawn by including the closest 100 sequences that were hit when the 
AU19 gene sequences was blasted against the GenBank database (VP7, VP4, NSP3, NSP4) 
or all sequences in the same genotype (VP1, VP2, VP3, NSP1, NSP2, NSP5).  
6.5. Nucleotide sequence accession numbers 
The sequences (n=35) of the VP7 genes were submitted to the DDJB/GenBank/EMBL 
databases and were assigned accession numbers AB821311-AB821345 (Table 2.1).  
The nucleotide sequences for the VP4, VP6, VP1-VP3, and NSP1-NSP5 genes of 
AU19 were deposited in the DDJB/GenBank/EMBL databases under accession numbers 
AB770153 – AB770162 (Table 6.2). 
Table 6.2. The accession number, year of detection and place where the strains were detected. 
Strain Year of detection Place of detection Accession number 
83A001 1983 Akita Prefecture AB770153 
85A21140 1985 Akita Prefecture AB770154 
86A005 1986 Akita Prefecture AB770155 
86Y1329 1986 Yamagata Prefecture AB770156 
86Y187 1986 Yamagata Prefecture AB770157 
87Y1438 1987 Yamagata Prefecture AB770158 
87Y003 1987 Yamagata Prefecture AB770159 
87H038 1987 Akita Prefecture AB770160 
88F007 1988 Akita Prefecture AB770161 
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88Y259 1988 Yamagata Prefecture AB770162 
88H449 1988 Akita Prefecture AB770163 
88Y1112 1988 Yamagata Prefecture AB770164 
89H354 1989 Akita Prefecture AB770165 
89A049 1989 Akita Prefecture AB770166 
89Y1520 1989 Yamagata Prefecture AB770167 
89H279 1989 Akita Prefecture AB770168 
90H377 1990 Akita Prefecture AB770169 
90Y289 1990 Yamagata Prefecture AB770170 
90Y593 1990 Yamagata Prefecture AB770171 
90H094 1990 Akita Prefecture AB770172 
01R137 2001 Akita Prefecture AB770173 
01P12 2001 Akita Prefecture AB770174 
01P7 2001 Akita Prefecture AB770175 
01P129 2001 Akita Prefecture AB770176 
01P17 2001 Akita Prefecture AB770177 
01P14 2001 Akita Prefecture AB770178 
01P8 2001 Akita Prefecture AB770179 
07Y03 2007 Yamagata Prefecture AB770180 
80004 2008 Nara Prefecture AB770181 
80120 2008 Nara Prefecture AB770182 
80123 2008 Nara Prefecture AB770183 
90096 2008 Nara Prefecture AB770184 
B100005 2011 Nara Prefecture AB770185 
B100056 2011 Nara Prefecture AB770186 




(At the time of thesis submission) 
Since the submission of two papers on which this thesis was prepared (10 May, 2013, 
and 1 July, 2013, respectively), more than two years have passed during which there is 
remarkable progress that has significant implication on the guestions I addressed in the AU19 
paper; one by myself and another by other investigators. 
The most common VP7 genotype of human RVA is G1, but G1 is rarely detected in 
porcine strains. To understand the evolutionary implications of AU19, I sequenced the VP7 
genes of three Japanese G1 porcine strains, two isolated in 1980 (PRV2, S80B) and one in 
2001 (Kyusyu-14), and performed phylogenetic and in-silico structural analyses. All three 
VP7 sequences clustered into lineage VI, which was 14.2% divergent from human G1 VP7 
sequences belonging to lineages I-V. The VP7 genes of PRV2 and AU19 were 98% identical, 
strengthening the porcine RVA origin of AU19. The phylogenetic tree showed human G1 
VP7 genes were originated from porcine G1 VP7 genes. The time of their most recent 
common ancestor was 1948, and human and porcine RVA strains evolved along independent 
pathways. In-silico structural analyses identified seven amino acid residues within the known 
neutralisation epitopes that show differences in electric charges or shape between porcine and 
human G1 strains. When compared with much divergent porcine G1 VP7 lineages, 
monophyletic, less divergent human G1 VP7 lineages support the hypothesis that all human 
G1 VP7 genes originated from a rare event of a porcine RVA transmitting to humans which 
was followed by successful adaptation to the human host. By contrast, AU19 represents 
interspecies transmission that terminated in dead-end infection. 
Another significant observation was made by Nagai, et al. and published recently in 
Vet Microbiol (176: 250-256, 2015). The paper showed evidence that three porcine RVA 
strains detected in Japan in 2014 had the H2b genotype in their NSP5 genes and super-short 
RNA patterns. The observation by Nagai et al. prompted me to re-consider the conclusion I 
77 
 
drew that AU19 was resulted from interspecies transmission of a porcine RVA strain to a 
child coupled with acquisition of an H2 gene by genetic reassortment with co-circulating 
human RVA strains. The circulation of porcine RVA carrying H2b does not require to 
hypothesise the acquisition of a rare H2b gene by genetic reassortment with human RVA. The 
acquisition of an H2b gene, in turn, requires to hypothesise persistent human-to-human 
transmission of a precursor of AU19 in order to allow reassortment to occur. As such rare 
events are not neccesary to hypothesise, it is more likely that AU19 was a fully porcine RVA 
at the time of jumping to infect a human. This scenario also agrees better with the observation 
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